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ABSTRACT
Background. Surfactant protein C (SP-C; 35 residues) in lungs has a cationic
N-terminal domain with two cysteines covalently linked to palmitoyls and a
C-terminal region enriched in Val, Leu and Ile. Native SP-C shows high surface
activity, due to SP-C inserting in the bilayer with its cationic N-terminus bind-
ing to the polar headgroup and its hydrophobic C-terminus embedded as a tilted,
transmembrane α-helix. The palmitoylcysteines in SP-C act as ‘helical adjuvants’ to
maintainactivitybyoverridingtheβ-sheetpropensitiesofthenativesequences.
Objective. We studied SP-C peptides lacking palmitoyls, but containing glutamate
and lysine at 4-residue intervals, to assess whether SP-C peptides with salt-bridges
(“ion-locks”) promote surface activity by mimicking the α-helix and membrane
topographyofnativeSP-C.
Methods. SP-C mimics were synthesized that reproduce native sequences, but with-
out palmitoyls (i.e., SP-Css or SP-Cff, with serines or phenylalanines replacing the
two cysteines). Ion-lock SP-C molecules were prepared by incorporating single or
double Glu−–Lys+ into the parent SP-C’s. The secondary structures of SP-C mimics
were studied with Fourier transform infrared (FTIR) spectroscopy and PASTA, an
algorithm that predicts β-sheet propensities based on the energies of the various
β-sheet pairings. The membrane topography of SP-C mimics was investigated with
orientatedandhydrogen/deuterium(H/D)exchangeFTIR,andalsoMembranePro-
tein Explorer (MPEx) hydropathy analysis. In vitro surface activity was determined
using adsorption surface pressure isotherms and captive bubble surfactometry, and
in vivo surface activity from lung function measures in a rabbit model of surfactant
deficiency.
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each form parallel β-sheet aggregates, with FTIR spectroscopy confirming high
parallel β-sheet with ‘amyloid-like’ properties. The enhanced β-sheet properties
for SP-Css and SP-Cff are likely responsible for their low surfactant activities in
the in vitro and in vivo assays. Although standard 12C-FTIR study showed that the
α-helicityoftheseSP-CsequencesinlipidswasuniformlyincreasedwithGlu−–Lys+
insertions, elevated surfactant activity was only selectively observed. Additional
results from oriented and H/D exchange FTIR experiments indicated that the high
surfactant activities depend on the SP-C ion-locks recapitulating both the α-helicity
and the membrane topography of native SP-C. SP-Css ion-lock 1, an SP-Css with a
salt-bridgeforaGlu−–Lys+ ion-pairpredictedfromMPExhydropathycalculations,
demonstrated enhanced surfactant activity and a transmembrane helix simulating
thoseofnativeSP-C.
Conclusion.HighlyactiveSP-Cmimicsweredevelopedthatreplacethepalmitoylsof
SP-Cwithintrapeptidesalt-bridgesandrepresentanewclassofsyntheticsurfactants
withtherapeuticinterest.
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INTRODUCTION
Lungsurfactantisamixtureoflipidsandproteinsthatiscriticalfornormalbreathingdue
toitsabilitytopreventalveolarcollapseduringexpirationbyreducingalveolarsurfaceten-
sion to extremely low values. Surfactant is synthesized and secreted into the alveolar fluid
by alveolar type II cells and consists of approximately 80% phospholipids, 10% neutral
lipids, and 10% proteins (Goerke, 1998). Although dipalmitoyl phosphatidylcholine and
phosphatidylglycerolconstitutetheprincipalphospholipidcomponentsinlungsurfactant,
its biophysical activities largely depend on the presence of the hydrophobic surfactant
protein B (SP-B) and, to a lesser degree, the extremely hydrophobic surfactant protein C
(SP-C)(Waltheretal.,2007a).Pioneeringsurfactanttherapyusingbovineorporcinelung
extracts, which consists of polar lipids and native SP-B and SP-C, has greatly improved
the outcome of premature infants with neonatal respiratory distress syndrome (NRDS)
(Polin & Carlo, 2014). On the other hand, replacement surfactant therapies using animal
preparations have not been successful in clinical trials of pediatric and adult patients
with acute lung injury (ALI) and acute respiratory distress (ARDS) (Brower & Fessler,
2011; Willson et al., 2013). A major goal of current research is to replace animal-derived
formulationsforthevarioussurfactantdeficiencieswithtotalsyntheticsconsistingofSP-B
andSP-Cmimics,producedbyrecombinanttechnologyorpeptidesynthesis,andselected
synthetic lipids (Curstedt, Calkovska & Johansson, 2013; Walther et al., 2005; Walther et al.,
2007b;Waltheretal.,2010;Waltheretal.,2014;Spraggetal.,2011;Almlenetal.,2010).
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 2/42Figure 1 Amino-acid sequences (1-letter codes) for native SP-C proteins and SP-C mimic pep-
tides. Human, dog and pig SP-C are the native sequences (35 or 34 residues), with palmitoyl groups
(not shown) attached to the Cys residues in the N-terminal domain. SP-C mimics are based on the native
sequences, except that the palmitoylcysteines have been replaced by Phe or Ser residues. The SP-C mimic
sequences have been slightly shifted to permit maximal overlaps with the SP-C protein sequences. rSP-C
is a 35-residue, recombinant form of human SP-C, with Phe residues replacing Cys-4 and Cys-5 and Ile
replacing Met-32; SP-C33 UCLA has the same sequence as the conventional SP-C33; SP-Cff ion-lock 1
is SP-Cff(E20/K24), SP-Css ion-lock 1 is SP-Css(E20/K24) and SP-C33 ion-lock 1 is SP-C33(E20/K24),
each with an ion-lock between Glu−-20 and Lys+-24. SP-C33 ion-lock 2 is SP-C33(K15/E19; E20/K24),
with ion-locks between Lys+-15 and Glu−-19 and between Glu−-20 and Lys+-24. Paired glutamates
and lysines are underlined red residues, with salt-bridges represented as red lines. The SP-Cff and SP-Css
mimicsareeach34-residueslong(exceptforrSP-C)andbasedonthenativeSP-Cclass,whilethosebased
on the SP-C33 class are 33-residues.
SP-C is a short (35 amino acids; MW of 4.2 kDa in humans) protein that is highly
enriched in valine, leucine and isoleucine residues, making it much smaller and more
hydrophobic than SP-B (79 amino acids; MW of 8.7 kDa) (Walther et al., 2007a). Mature
SP-C has an N-terminus with a pair of vicinal cysteine residues that are covalently linked
to palmitoyl moieties via thioester bonds (Fig. 1), thereby producing a true proteolipid
(Curstedt et al., 1990). The only exception to this vicinal cysteine pairing is found in dog
SP-C, which has one palmitate substituted by a phenylalanine (Fig. 1) (Johansson et al.,
1991).ThepalmitoylatedgroupsinSP-Careadjacenttoashortpolar,N-terminalsegment,
characterized by cationic residues such as lysine and arginine (Fig. 1). Native SP-C is
polymorphic and often has truncations in the N-terminal domain varying from one to
threeresidues.ThepolarN-terminalregionofSP-C(residues∼1–8)isfollowedbyahighly
conserved and hydrophobic C-terminal sequence enriched in polyvaline that spans for
∼26 residues (9–34) to close to the C-terminus (Fig. 1). Prior Fourier transform infrared
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in surfactant lipid bilayers. Moreover, FTIR spectra indicated that SP-C’s long molecular
axis was deeply embedded as a transmembrane helix using, hydrogen/deuterium (H/D)
exchange and at a slight tilt to the membrane normal with orientation-dependent FTIR
analysis (Vandenbussche et al., 1992; Pastrana, Maulone & Mendelsohn, 1991). Subsequent
two-dimensionalnuclearmagneticresonance(2D-NMR)ofporcineSP-Cinalipid-mimic
indicated an unstructured N-terminus (residues ∼1–8), while residues ∼9–34 formed an
α-helix in the mid- and C-terminal regions (PDB accession code: 1SPF) (Johansson et al.,
1994). Additional physical studies indicated that the cationic N-terminal domain of SP-C
is limited to the surface of phospholipid bilayers and has a higher affinity for anionic than
zwitterionic lipids (Plasencia et al., 2004). In agreement with these experimental results,
recent Molecular Dynamics simulations predicted that SP-C and its attached palmitoyls
penetrate deeply into lipid monolayers (Baoukina & Tieleman, 2010; Duncan & Larson,
2010). MD simulations also confirmed that SP-C embeds into bilayers with its helical axis
and palmitoyl groups nearly parallel to the fatty acyl chains and its cationic N-terminal
regionrestrictedtothemembraneheadgroup(Baoukina&Tieleman,2010).
Previous in vitro and in vivo studies have demonstrated that helical SP-C mediates
important surfactant activities in the human lung (Walther et al., 2007a; Johansson, 1998).
With or without the covalent-linked palmitoyl groups, SP-C was shown using various
physical techniques to stabilize phospholipid bilayer ensembles that remain attached to
the monolayer at the air–water interface. Such adducts may constitute a surfactant lipid
‘reservoir’enrichedinSP-Cthatmaintainsthelipidmonolayerthroughouttherespiration
cycle(vonNahmenetal.,1997;Krameretal.,2000;Dingetal.,2001;Takamotoetal.,2001).
The presence of SP-C in lung surfactant also enhances the resistance to surfactant flow by
increasing surface viscosity (Alonso & Zasadzinski, 2004). SP-C plays a lesser role in lung
surfactant activities than SP-B. Complete absence of SP-B is lethal in human newborns
and animals (Clark et al., 1995), but animals with an SP-C mutation are viable with a
diseasethatdisruptslungdevelopment(Bridgesetal.,2003)andincreasessusceptibilityto
infection (Bridges et al., 2006). Thus, a total synthetic replacement that successfully treats
patients with surfactant deficiencies is likely to include mimics of both SP-B and SP-C
proteins(Curstedt,Calkovska&Johansson,2013;Almlenetal.,2010;Waltheretal.,2014).
Prior investigations indicate that the two palmitoylated cysteine moieties of SP-C
play critical roles in the structural and functional properties of this surfactant protein.
These neighboring palmitoyl groups stabilize the α-helix of SP-C (Vandenbussche et al.,
1992; Pastrana, Maulone & Mendelsohn, 1991; Johansson et al., 1994; Wang et al., 1996;
Johanssonetal.,1995;Dluhyetal.,2003)andminimizetheformationofβ-sheetoligomers
(Johansson, 1998; Gustafsson et al., 1999), optimize surface active interactions with lipids
(Wangetal.,1996;Baumgartetal.,2010),andmayinduceacouplingbetweenneighboring
layersandeventriggerastackingofbilayers(Baumgartetal.,2010;NaNakornetal.,2007).
Although SP-C exists primarily as a dipalmitoylated, α-helical monomer in bovine lung
lavage,thereisalsoaminordimericcomponent(∼10%)thatisdepalmitoylated (i.e.,lacks
the two palmitoyls) and exhibits predominantly intermolecular β-sheet and abnormal
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SP-C are also connected to pulmonary alveolar proteinosis. Voss et al. (1992) earlier
reported that partially, or even completely, depalmitoylated SP-C, was present in the
bronchoalveolar fluid of patients with pulmonary alveolar proteinosis, and suggested
thatthispathologicalmodificationmayreducesurfactantfunction.Thishypothesisisalso
supported by the diminished in vitro surfactant activities seen with chemically deacylated
SP-C (Wang et al., 1996), and also the high β-sheet observed with non-palmitoylated
SP-C fibrils using FTIR spectroscopy (Dluhy et al., 2003). More recently, SP-C, with or
without palmitoyls, has been identified in the insoluble aggregates of pulmonary alveolar
proteinosis fluid and shows characteristic amyloid properties such as Congo red staining
andalveolarfibrilformationonelectronmicroscopy(Gustafssonetal.,1999).Mutationsin
theSP-Cgenehavebeenassociatedwithfamilialinterstitiallungdisease(Nogeeetal.,2001)
and accumulation and misrouting of incorrectly folded proteins (Whitsett, 2002). Direct
observations of amyloid deposits containing mature SP-C in lung tissue from interstitial
lung disease patients with mutations in the BRICHOS domain strongly support this asso-
ciation (Willander et al., 2012). Altogether the various structural studies demonstrate that
SP-C is metastable in lipid environments and may partially convert from predominately
α-helixintoinsolubleandinactive‘amyloid-like’fibrilsconsistingofβ-sheet.
An early approach to developing SP-C mimics for surfactant replacement therapy was
to largely reproduce the sequences of native SP-C using chemically synthesized or recom-
binantmolecules.Thesefirst generationSP-Cmimicsprimarilyfollowthenativesequence,
but typically omit the covalently attached palmitoyl groups to simplify peptide synthesis
and purification. For example, the 34-residue SP-Css mimic principally uses the human
SP-C sequence as a template but substitutes the palmitoylcysteine groups with serine
residues (Fig. 1). The serine replacements approximate the stereochemistry, hydropathy
and net charge of native cysteine without being subject to oxidative side-reactions, and
thus SP-Css may be a more stable mimic of depalmitoylated SP-C. The 34-residue SP-Cff
(Fig. 1) also uses human SP-C as a template but the palmitoylcysteine groups are replaced
withphenylalaninestosimulatedipalmitoylated SP-C.Becauseoneofthepalmitatesindog
SP-C is replaced by phenylalanine (Fig. 1) (Johansson et al., 1991), SP-Cff might exhibit
highsurfactantactivitybecauseitstwophenylalanineshavebulkyhydrophobicsidechains
that may reproduce theinsertion of palmitoyls into the hydrophobicinterior of surfactant
lipid monolayers/bilayers. Unfortunately, research on chemically synthesized, 35-residue
SP-Css or SP-Cff indicated diminished in vitro surfactant activities in comparison with
native SP-C and this may be related to their reduced helical content in lipid environments
(Johansson et al., 1995). In agreement with these findings, synthetic 34-residue SP-Cff
(Fig. 1) showed low solubility in chloroform-methanol, and was difficult to formulate
with Tanaka lipids in an active α-helical conformation (Walther et al., 2000). A range of
in vitro,in vivoandclinicalstudieshaveassessedthestructuralandfunctionalpropertiesof
a recombinant, 35-residue SP-Cff (i.e., rSP-C or Venticute® in Fig. 1). Extensive 2D-NMR
analyses (Luy et al., 2004; Kairys, Gilson & Luy, 2004) indicated that freshly prepared
recombinant SP-C in chloroform-methanol is a mixture of monomers and dimers,
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porcine SP-C (Johansson et al., 1994). Non-palmitoylated rSP-C shares key metastable
characteristicsofnativeporcineSP-Cwhensuspendedinchloroform-methanolforseveral
days, such as the conversion of α-helical conformers to insoluble β-sheet multimers
(Luy et al., 2004). Although early in vivo studies with this recombinant SP-Cff showed
surfactant activities closely resembling those of native SP-C (Ikegami & Jobe, 1998), a
recent clinical trial of patients with ARDS demonstrated that rSP-C surfactant neither
decreased mortality nor improved patient oxygenation (Spragg et al., 2011). Pulsating
bubble surfactometry results suggested that this may have been due to a partial surfactant
inactivation during resuspension of rSP-C prior to administration (Spragg et al., 2011).
Consequently, the low or unstable surfactant activities observed for the above SP-Css and
SP-Cffpeptides(Fig.1)arguethatfurthersequencechangesarerequiredtoproducemore
effective,non-palmitoylatedSP-Cmimics.
Accordingly, a second generation of SP-C mimics lacking palmitoyl groups, but with
enhanced α-helical content and surfactant activities through amino-acid substitutions in
the primary sequence, is now being developed for surfactant replacement therapy. The
chemically synthesized SP-C33 (Fig. 1) is a second generation SP-C mimic, in which the
adjacent palmitoylcysteine groups are replaced with serines and the poly-valines in the
α-helix are substituted with multiple leucines. In vitro and in vivo studies demonstrated
surfactant activities for this SP-C33 analog comparable to those of native SP-C (Johansson
et al., 2003; Almlen et al., 2011) and this may be because SP-C33 and native SP-C both
similarly insert into surfactant lipids as slightly tilted, transmembrane α-helices (Vanden-
bussche et al., 1992; Pastrana, Maulone & Mendelsohn, 1991; Almlen et al., 2011). These
results support the hypothesis that the manipulation of native sequences may produce
SP-C mimics with enhanced α-helicity and surfactant activity. However, SP-C33 may not
becompletelyoptimizedforsuchimportantcharacteristicsassurfactantactivity(aloneor
in combination with other surfactant components such as SP-B mimics), resistance to in-
hibition, toxicity or shelf-life stability. Less invasive second generation SP-C mimics using
fewersubstitutionsmaypermitmoreaccuratecontrolovercriticalsurfactantproperties.
Another strategy for obtaining second generation SP-C mimics without palmitoyl
groups involves the introduction of charged ion-pairs (i.e., ‘salt-bridges’ or ‘ion-locks’)
intoSP-Cpeptides,inwhichthecationicLys+ orArg+ residuesinteractwithanionicGlu−
or Asp− residues. In Circular Dichroism (CD) experiments, Marqusee & Baldwin (1987)
showed that incorporation of Lys+ and Glu− at intervals of 4 residues (i.e., “i+4”) in the
sequencesubstantiallyincreasedthehelixcontentofthehostpeptide.Thisstabilizationof
the helix in aqueous environments is due to the formation of an electrostatically neutral
ion-pairviathepositive-andnegative-chargedsidegroupsfortheLys+ andGlu− residues.
Using an augmented Wimley-White (WW) hydrophobicity scale, which accounts for
whole-residue energy contributions by the peptide backbone, side-chains and salt-bridge
pairs, Membrane Protein Explorer (MPEx) analyses predicted that ‘ion-locks’ such as
Glu−–Lys+ may increase the helicity and lipid-partitioning of peptides and proteins in
membranes (Snider et al., 2009). Because the formation of an ion-pair is electrostatically
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the hydrophobic residues of a transmembrane sequence with an ‘ion-lock’ pairing
(e.g., Glu− and Lys+) (Jayasinghe, Hristova & White, 2001). Salt-bridges (or ‘ion-locks’)
have been found in numerous proteins such as Ca2+-ATPase, which has a membrane
helix stabilized by an intrahelical charge-pair when facing lipids (Bano-Polo et al.,
2012). Importantly, electrostatic calculations indicated that salt-bridges with close-range
distances (≤4.0 ˚ A) between the cationic residue “N” and the nearest anionic residue “O”
are mostly α-helix stabilizing, while those with long-range distances (>5 ˚ A) may be helix
destabilizing(Kumar&Nussinov,1999;Kumar&Nussinov,2002).
In the present study, we synthesized peptides representing the native sequence of SP-C
(SP-Css and SP-Cff) lacking palmitoyl groups, an SP-C mimic with elevated surfactant
activity (SP-C33 UCLA), and SP-C mimics with single or double salt-bridges in the
mid-section of the hydrophobic C-terminal region (i.e., SP-Css ion-lock 1, SP-Cff
ion-lock 1, SP-C33 ion-lock 1 and SP-C33 ion-lock 2; see Fig. 1). FTIR spectroscopy
of SP-Css and SP-Cff in surfactant lipids, an aqueous buffer or a α-helix promoting
HFIP buffer (Crescenzi et al., 2002; Rajan et al., 1997) indicated elevated β-sheet, while
the corresponding spectra of the daughter SP-Css ion-lock 1 and SP-Cff ion-lock 1 in
these environments demonstrated low β-sheet and mostly high α-helix. However, FTIR
spectroscopy also indicated that the α-helicity of SP-Css ion-lock 1 in surfactant lipids
washigherthanthatofSP-Cffion-lock1.Furthermore,orientedandhydrogen/deuterium
(H/D) exchange FTIR spectra showed that an SP-Css ion-lock 1 incorporates into lipid
bilayersasaslightlytiltedtransmembraneα-helix,whileSP-Cffion-lock1withitsshorter
helix had a greater tilt and may be restricted to only one monolayer. Consequently, the
much higher in vitro and in vivo surfactant activities reported here for SP-Css ion-lock
thanforSP-Cffion-lock1areattributedtotheformerSP-Cmimicmorecloselysimulating
the enhanced α-helicity and membrane topography of the native dipalmitoylated SP-C.
These results provide a proof of concept that selective insertion of salt-bridge(s) may
produce stable and functional SP-C mimics that completely block the well-known
amyloidogenicpropensitiesoftheparentSP-Cprotein.
MATERIALS & METHODS
Ethics statement
The animal study was reviewed and approved by the Institutional Animal Care and Use
Committee of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical
Center (protocol # 12958). All procedures and anesthesia were performed in accordance
withtheAmericanVeterinaryMedicalAssociationguidelines.
Materials
All organic solvents for sample synthesis were HPLC grade or better. Phospholipids were
obtained from Avanti Polar Lipids, Inc. (Alabaster, AL). Deuterated water was NMR
qualityfromAldrichChemicalCo(St.Louis,MO).
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A suite of SP-C peptides, composed of the 34-residue SP-Cff, SP-Cff ion-lock 1, SP-Css
and SP-Css ion-lock 1 and the 33-residue SP-C33 UCLA, SP-C33 ion-lock 1 and SP-C33
ion-lock 2 (Fig. 1), was synthesized with FastMocTM (Fields et al., 1991) or standard
Fmoc procedures on a Leu-HMPB NOVA resin using ABI 431A (Applied Biosystems,
Foster City, CA), Symphony Multiple Peptide (Protein Technologies, Tucson, AZ) or
Liberty Microwave Peptide (CEM Corp, Matthews, NC) synthesizers. The SP-C mimic
peptides were each carboxylated at the C-terminus and amidated at the N-terminus,
and all residues were double-coupled to insure optimal yield (Waring et al., 2005).
C-terminal carboxyl SP-C peptides were cleaved from the resin using the standard
phenol:thioanisole:ethanedithiol water:trifluoracetic acid (0.75:0.25:0.5:0.5: 10, v:v)
cleavage-deprotection mixture (Walther et al., 2010). Crude peptides were then purified
(better than 95%) by preparative HPLC using a VYDAC diphenyl or C8 (1′′ by 12′′ width
by length) column at 20 ml/min. SP-C peptides were each eluted from the column with
a 0–100% (water to acetonitrile with 0.1% TFA as an ion pairing agent added to both
aqueous and organic phases) linear gradient in one hour. The purified product was
freeze-drieddirectlyandthemasswasconfirmedbyMaldiTOFmassspectrometry.
Attenuated total reflectance-fourier transform infrared (ATR-FTIR)
spectroscopy
Infrared spectra were recorded at 37 ◦C for selected SP-C peptides in Fig. 1 using a
Bruker Vector 22 FTIR spectrometer (Pike Technologies, Madison, WI) with a deuterium
triglyceridesulfate(DTGS)detector,averagedover256scansatagainof4andaresolution
of 2 cm−1 (Waring et al., 2005; Walther et al., 2007b; Walther et al., 2010; Gordon et al.,
2008). For spectral recordings of SP-C peptides in hexafluoroisopropanol (HFIP) or
aqueous buffer solutions, self-films were first prepared by air-drying peptide originally
in 100% HFIP onto a 50 × 20 × 2 mm, 45◦ germanium attenuated total reflectance
(ATR) crystal for the Bruker spectrometer. The dried peptide self-films were then overlaid
with solutions containing 35% HFIP/65% deuterated-10 mM sodium phosphate buffer
(pD 7.4) (Glasoe & Long, 1960) or 100% deuterated-10 mM sodium phosphate buffer
(pD 7.4) before spectral acquisition; control solvent samples were similarly prepared, but
withoutpeptide.Spectraofpeptidesinsolventwereobtainedbysubtractionofthesolvent
spectrum from that of the peptide-solvent. For FTIR spectra of SP-C peptides in synthetic
surfactant lipid multilayers (DPPC:POPC:POPG; weight ratio, 5:3:2), the peptide was
co-solvated with lipid systems in HFIP (lipid:peptide mole ratio of 10:1) and transferred
ontoanATRcrystal(PikeTechnologies).Theorganicsolventwasthenremovedbyflowing
nitrogen gas over the sample to produce a lipid-peptide film. The lipid-peptide films were
nexthydrated(≥35%)(Yamaguchietal.,2001)with10mMdeuteratedsodiumphosphate
buffer (pD 7.4) vapor in nitrogen for 1 h prior to acquiring spectra (Gordon et al., 2000;
Yamaguchi et al., 2002). The spectra for peptide in lipid mixtures were obtained by
subtractingthelipidspectrumhydratedwith10mMdeuteratedphosphatebuffer(pD7.4)
fromthatofpeptideinlipidwith10mMphosphatebuffer(pD7.4).Infraredspectrawere
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peptide self-films (see above). Relative amounts of α-helix, β-turn, β-sheet, or random
(disordered) structures in either peptide self-films or lipid-peptide films were estimated
using Fourier deconvolution (GRAMS/AI8, version 8.0, Themo Electron Corporation,
Waltham, MA) and area of component peaks calculated using curve-fitting software (Igor
Pro,version1.6,Wavemetrics,LakeOswego,OR)(Kauppinenetal.,1981).FTIRfrequency
limitswere:α-helix(1662–1645cm−1),β-sheet(1637–1613cm−1 and1710–1682cm−1),
turn/bend (1682–1662 cm−1), and disordered or random (1650–1637 cm−1)
(Byler&Susi,1986).
To estimate the orientation of the α-helix of various SP-C peptides in surfactant lipid
multilayers deposited on the germanium crystal surface, gold wire polarizers (Perkin
Elmer, Waltham, MA) were rotated from 0◦ to 90◦ to obtain polarized IR spectra of
each lipid-peptide film (Gordon et al., 1996). The insertion (or tilt) angle Θ for the SP-C
helical axis with respect to the normal of the germanium surface was calculated based
on the dichroic ratio R (Beevers & Kukol, 2006), which is equal to the ratio of Aparallel
to Aperpendicular. Here, Aparallel and Aperpendicular are defined as the respective areas of
absorbance at 0◦ (parallel) and 90◦ (perpendicular) polarizations for the amide I band
centered at ∼1656 cm−1. These measures assumed a thick film approximation with
the values for the electric field components of the evanescent wave to be Ex = 1.398,
Ey = 1.516, Ez = 1.625, and an angle α = 39◦ for the vibrational dipole relative to the
molecular axis of the helix to derive an order parameter S (Beevers & Kukol, 2006; Chia et
al., 2002). Here, S is equal to [(E2
x −RE2
y +E2
z)/(E2
x −RE2
y +E2
z)]÷[(3cos2α −1)/2]. The
experimental tilt angle, Θ, was then calculated from this order parameter, by noting that
S = (3cos2Θ−1)/2.However,itshouldbenotedthatthemultilayerpeptide-lipidsamples
stacked on the germanium crystal are unlikely to be perfectly ordered (Arkin, MacKenzie
&Brunger,1997;Kukoletal.,1999),andthisintroducesanisotropiccontributionthatwill
artificially reduce the dichroic ratio R. Accordingly, the experimental Θ angles obtained
herewithrespecttothegermaniumcrystalshouldbeviewedasmaximumtiltangles,with
the actual tilt angles with respect to the normal of the multilayer lipid surface likely to be
lower(Beevers&Kukol,2006).
For selected SP-C peptides in surfactant lipids, the stability of the α-helical component
was also analyzed by monitoring the hydrogen/deuterium (H/D) exchange for amide
protons with the FTIR spectrometer. The peptide-lipid sample on the ATR crystal
was flushed with 10 mM deuterated phosphate buffer (pD 7.4) vapor in nitrogen at
37 ◦C, and the decay of the amide II band area (1525–1565 cm−1) was determined as a
function of time (0–6 h) to assess the time-dependent H/D exchange of the amide group
(Vandenbusscheetal.,1992;Beevers&Kukol,2006;Almlenetal.,2011).
Prediction of aggregation-forming regions in SP-C peptides
SP-C peptides were analyzed with PASTA (Trovato et al., 2006; Trovato, Seno & Tosatto,
2007) to characterize those domains most likely to form β-sheet, particularly in polar
environments such as aqueous buffer or the lipid–water interface of membranes
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 9/42(Gordon et al., 2008). The PASTA algorithm systematically calculates the relative
energies of the various pairing arrangements by assessing a pair-wise energy function
for residues facing one another within a β-sheet. Using a database of known 3D-native
structures, PASTA computes two different propensity sets depending on the directionality
(i.e., parallel or antiparallel β-sheets) of the neighboring strands. PASTA assigns relative
energies to specific β-pairings of two sequence stretches of the same length, and assumes
thatthelowerrelativeenergiesenhanceaggregationbyfurtherstabilizingthecross-β core.
Theoretical PASTA predictions of SP-C and SP-C mimic aggregation were performed by
submitting the primary sequences of these peptides (Fig. 1) to the PASTA Version 1.1
(http://protein.cribi.unipd.it/pasta) website (Trovato, Seno & Tosatto, 2007). PASTA
calculates the relative energies of the most stable pairings (i.e., more negative energies
denote more stable conformations), and outputs them as an HTML file (maximum
pairings: 100). The PASTA energies for the top-ranked pairings may predict whether
the β-sheet domains of one peptide will be more stable than those of other peptides. The
energies for these pairings may also be used to compute an aggregation profile for those
regions within a peptide most likely to aggregate as β-sheets. One cautionary note in
usingthePASTAalgorithmisthatitdoesnotcorrectfortheactualenvironmentalpolarity
of a given protein domain, and also does not explicitly account for salt-bridges forming
betweenchargedion-pairs.
Hydropathy predictions of SP-C peptides inserting into lipid
bilayers as transmembrane helices
Membrane Protein Explorer (MPEx; Version 3.2.9) is a Java program that analyses
hydrophobic lipid–protein interactions in membranes (http://blanco.biomol.uci.edu/
mpex). With the hydropathy analysis mode (Snider et al., 2009), hydropathy plots are
producedusingtheaugmentedWimley-White(WW)whole-residuehydrophobicityscale
thatpredictstransmembranehelicesforproteinsequenceswithhighaccuracy(Jayasinghe,
Hristova & White, 2001; Liang et al., 2012). This augmented scale is experimentally based
on the partitioning of hydrophobic pentapeptides (Wimley, Creamer & White, 1996)
and salt-bridge pairs (Wimley et al., 1996) into n-octanol (i.e., solvent mimic of the
hydrocarbon (non-polar) region of the bilayer), and accounts for whole-residue energy
contributions due to the peptide backbone, side-chains and salt-bridge pairs (Jayasinghe,
Hristova & White, 2001; Snider et al., 2009). Protein sequences may be submitted to the
MPEx program, and the resulting plots are presented as hydropathy (kcal/mol) versus the
sequence residue number, averaged over a sliding window of 19 amino-acid residues.
Higher positive hydropathy values reflect enhanced lipid bilayer partitioning for any
putative membrane helices. The default scale for the hydropathy analysis uses n-octanol,
and there is an option for engaging potential salt-bridges using an “on–off” switch on the
MPExcontrolpanel.
In vitro adsorption surface pressure measurements
Adsorptionexperimentsweredoneat37±0.5 ◦CinaTeflon® dishwitha35mlsubphase
(0.15 M NaCl + 1.5 mM CaCl2) stirred to minimize diffusion resistance as described
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 10/42previously(Notter,Finkelstein&Taubold,1983).Surfactantswerepreparedbyco-solvating
thelipidcomponents(i.e.,DPPC:POPC:POPG,5:3:2,weightratio)withtheSP-Cpeptide
in organic solvent HFIP (100%), dried under nitrogen, exposed to house vacuum to
remove residual solvent, resuspended by hand vortexing in 0.15 M NaCl (normal saline)
adjusted to pH 7.0 with 0.1 N sodium bicarbonate, heated to 65 ◦C intermittently for
30 min, and refrigerated for 12 h prior to use. At time zero, a bolus of these surfactant
preparationscontaining2.5mglipidin5mlof0.15MNaCl+1.5mMCaCl2 wasinjected
intothestirredsubphase,andadsorptionsurfacepressure(surfacetensionloweringbelow
that of the pure subphase) was measured as a function of time by the force on a partially
submerged, sandblasted platinum Wilhelmy slide (Notter, Finkelstein & Taubold, 1983).
The final surfactant concentration for adsorption studies was uniform at 0.0625 mg
phospholipid/ml(2.5mgsurfactantphospholipid/40mloffinalsubphase).
In vitro surfactant activity measured with captive bubble
surfactometry
Adsorption and dynamic surface tension lowering ability of all above described surfactant
preparations were measured with a captive bubble surfactometer at physiological cycling
rate, area compression, temperature, and humidity (Walther et al., 2010). We routinely
analyze surfactant samples of 1 µl (35 mg phospholipids/ml) in the captive bubble
surfactometerandperformallmeasurementsinquadruplicate.
Ventilated, lung-lavaged, surfactant-deficient rabbit model
Young adult New Zealand white rabbits (weight 1.0–1.3 kg) received anesthesia with
50 mg/kg of ketamine and 5 mg/kg of acepromazine intramuscularly prior to placement
of a venous line via a marginal ear vein. After intravenous administration of 1 mg/kg of
diazepam and 0.2 mg/kg of propofol, a small incision was made in the skin of the anterior
neck for placement of an endotracheal tube and a carotid arterial line. After placement
of the endotracheal tube muscle paralysis was induced with intravenous pancuronium
(0.1 mg/kg). During the ensuing duration of mechanical ventilation anesthesia was
maintained by continuous intravenous administration of 3 mg/kg/h of propofol and
intravenousdosagesof1mg/kgofdiazepamasneeded;muscleparalysiswasmaintainedby
hourlyintravenousadministrationof0.1mg/kgofpancuronium.Heartrate,arterialblood
pressures and rectal temperature were monitored continuously. Respiratory function was
followedduringmechanicalventilationbymeasurementsofserialarterialbloodgasesand
pulmonarycomplianceoverthefirst2hafterastandardizedsalinelavageprotocol.Forthis
timeframeofstudy,themodelreflectedarelativelypurestateofsurfactantinsufficiencyin
animalswithmaturelungs.
After stabilization on the ventilator, saline lavage was performed with repeated
intratracheal instillation and removal of 30 mL of normal saline until the PaO2 dropped
below 100 mm Hg (average 3 lavages). Maintenance fluid was provided by a continuous
infusion of Lactated Ringer’s solution at a rate of 10 ml/kg/h. Edema fluid appearing in
the trachea was removed by suctioning. When the PaO2 was stable at less than 100 mm
Hg in saline lavaged animals, an experimental or control surfactant mixture was instilled
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 11/42into thetrachea ata dose of100 mg/kg bodyweight anda concentration of35 mg/ml. The
rabbitswereventilatedusingaHarvardvolumecontrolledanimalventilator(tidalvolume
7.5 ml/kg, a positive end-expiratory pressure of 3 cm H2O, an inspiratory/expiratory
ratio of 1:2, 100% oxygen, and a respiratory rate to maintain a PaCO2 at ∼40 mm
Hg). Airway flow and pressures and tidal volume were monitored continuously with
a pneumotachograph connected to the endotracheal tube and a pneumotach system.
Arterial pH and blood gases were done every 15 min. Dynamic lung compliance was
calculated by dividing tidal volume/kg body weight by changes in airway pressure (peak
inspiratory pressure minus positive end-expiratory pressure) (ml/kg/cm H2O). Animals
were sacrificed 2 h after surfactant administration with an overdose of pentobarbital.
End-pointswerepulmonarygasexchange(arterialpH,PaCO2 andPaO2)andpulmonary
mechanics(dynamiccompliance).
RESULTS
FTIR spectroscopic analysis of the secondary conformations for
SP-C mimics with and without ion-locks
To test the structural effects of inserting ion-locks into SP-C peptides, a suite of SP-C
mimics was prepared based on native SP-C sequences (i.e., SP-Css and SP-Cff) and
these native SP-C sequences with a Glu−–Lys+ pairing in the hydrophobic midsection
(i.e., SP-Css ion-lock 1 and SP-Cff ion-lock 1; see Fig. 1). Representative FTIR spectra of
the amide I band for SP-Css and SP-Cff in surfactant lipids (DPPC:POPC:POPG 5:3:2,
weight ratio) in Fig. 2A were similar, each showing a major β-sheet component with a
predominantpeakat∼1630–1631cm−1 andaminisculecompanionpeakat∼1691cm−1,
and a lower α-helical component with a mid-field shoulder at ∼1657 cm−1. Subsequent
deconvolutions confirmed that SP-Css and SP-Cff in surfactant lipids principally adopt
β-sheet conformations (≥∼58%) with minor contributions from α-helix, loop-turn
and disordered structures (Table 1). In additional studies (Table 2), FTIR spectra and
deconvolutions for SP-Css and SP-Cff in a membrane-interfacial lipid mimic (i.e., 35%
HFIP/65% deuterated-sodium phosphate buffer, pD 7.4) or 100% aqueous buffer
(i.e., 10 mM deuterated phosphate buffer, pD 7.4) indicated comparably high β-sheet
(≥36%–50%), with smaller proportions from other conformations. Consistent with
these findings, prior FTIR spectroscopy of 34-residue SP-Cff showed reduced α-helix
on short-term storage in surfactant lipids (Walther et al., 2000), while earlier CD analyses
of synthetic, 35-residue SP-Css or SP-Cff in detergent micelles also indicated enhanced
β-sheet and reduced α-helix (<20%) (Johansson et al., 1995). In our hands, SP-Css and
SP-Cff exhibited only high β-sheet and low α-helix in surfactant lipids (Fig. 2; Table 1) or
environmentsofdifferingpolarity(Table2).
FTIR spectroscopy determinations for either SP-Css ion-lock 1 or SP-Cff ion-lock 1
in surfactant lipids indicated enhanced α-helix and reduced β-sheet, when compared to
the corresponding measurements of the native SP-Css or SP-Cff sequences. For example,
FTIR spectra of SP-Css ion-lock 1 in surfactant lipids (Fig. 2A) indicated high α-helix
(at ∼1657 cm−1), and very low β-sheet (at ∼1630 cm−1). Importantly, deconvolution
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 12/42Figure 2 FTIR spectra of the amide I bands for SP-C mimic peptides in surfactant lipids
(DPPC:POPC:POPG 5:3:2). (A) SP-Css is the dashed red line, SP-Css ion-lock 1 is the solid red-line,
SP-Cff is the dashed black line and SP-Cff ion-lock 1 is the solid black line. The spectra for either
SP-Css or SP-Cff in surfactant lipids with 10 deuterated mM phosphate buffer (pD 7.4) principally
show β-sheet, with a major peak at 1630–1631 cm−1 and a very low companion peak at ∼1691 cm−1.
The SP-Css and SP-Cff spectra also show significant shoulders at ∼1653–1657 cm−1, indicating minor
α-helical structures. The corresponding spectra for SP-Css ion-lock 1 and SP-Cff ion-lock 1 in surfactant
lipids primarily show α-helix with maxima at ∼1653–1657 cm−1, indicating that incorporation of the
Glu−–Lys+ ion-pair in either SP-C mimic effectively reverses their β-sheet properties. (B) SP-C33 UCLA
is a solid magenta line, SP-C33 ion-lock 1 is a solid green line, and SP-C33 ion-lock 2 is a solid blue line.
The spectra for SP-C33 UCLA and the SP-C33 ion-locks in lipids all closely overlap, with shared maxima
at ∼1655 cm−1 indicating predominate α-helix. The introduction of a single or double Glu−–Lys+
ion-pair in SP-C33 does not raise the α-helical levels over that seen with the parent SP-C33 UCLA
(Table 1). Peptide concentrations were 470 µM, and sequences are in Fig. 1. FTIR spectra for peptide
in lipid mixtures (Figs. 2A and 2B) were obtained by subtracting the lipid spectrum hydrated with 10
mM deuterated phosphate buffer (pD 7.4) from those of peptides in lipid with 10 mM phosphate buffer
(pD 7.4).
Table1 Proportionsofsecondarystructurea andmaximumtiltangles(Θ)ofthemembraneα-helixb for
SP-C peptide mimics in synthetic surfactant lipidsc with 10 mM deuterated phosphate buffer (pD 7.4),
as estimated from the ATR-FTIR spectra of the peptide amide I band.
System %Conformationa Max.tiltangleb
α-helix β-sheet Loop-turn Disordered θ
DPPC:POPC:POPGc
SP-Cff 5.6 74.3 2.9 17.2 —
SP-Cff ion-lock 1 44.6 17.8 15.7 22.0 34.2◦
SP-Css 24.5 58.6 9.1 7.9 —
SP-Css ion-lock 1 63.1 5.5 25.5 5.9 22.6◦
SP-C33 67.2 6.9 13.9 12.0 22.5◦
SP-C33 ion-lock 1 66.9 3.6 21.7 7.8 22.7◦
SP-C33 ion-lock 2 65.1 7.7 18.0 9.18 23.2◦
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 13/42Table 2 Proportions of secondary structure for SP-C peptide mimics in deuterated phosphate and
hexafluoroisopropanol buffer. Proportions of secondary structurea for SP-C peptide mimics in 10 mM
deuterated phosphate buffer (dPBS, pD 7.4) and 35% hexafluoroisopropanol (HFIP)/65% dPBS, as
estimated from the ATR-FTIR spectra of the peptide amide I band.
System %Conformationa
α-helix β-sheet Loop-turn Disordered
dPBS
SP-Cff 7.4 51.9 24.0 10.6
SP-Cff ion-lock 1 17.8 2.9 59.9 19.5
SP-Css 15.8 49.7 14.6 19.9
SP-Css ion-lock 1 40.8 11.8 18.8 28.7
SP-C33 UCLA 50.0 14.4 17.2 18.4
SP-C33 ion-lock 1 57.8 14.8 12.2 15.1
35% HFIP/dPBS
SP-Cff 19.3 53.2 17.8 9.7
SP-Cff ion-lock 1 53.0 13.9 16.9 16.1
SP-Css 18.5 35.6 22.1 23.9
SP-Css ion-lock 1 51.1 10.4 33.1 5.45
SP-C33 UCLA 52.6 14.1 18.6 14.7
SP-C33 ion-lock 1 49.6 8.01 1.42 13.7
showedpredominantα-helix(i.e.,∼63%)andminorβ-sheet(∼6%)forSP-Cssion-lock1
in surfactant lipids, as opposed to the reduced α-helix (∼25%) and elevated β-sheet
(∼58%) determined from FTIR spectra of its parent SP-Css in this environment (Fig.
2A; Table 1). Consequently, insertion of the ion-lock (i.e., Glu−-20–Lys+-24) in the mid-
section of the poly-Val sequence produced a remarkable conformation shift in the host
SP-Css, from an ‘amyloid-like’ β-sheet profile to one that is primarily α-helix (Fig. 2A).
Additional FTIR spectra of SP-Css ion-lock 1 in aqueous and membrane-interfacial HFIP
milieu also demonstrated elevated α-helix values (≥ ∼41%) over those obtained for the
parentSP-Css(Table2),suggestingthatanintrapeptidesalt-bridge(atGlu−-20–Lys+-24)
stabilizes the α-helical conformation in environments of differing polarity. In further
studies, FTIR spectra of SP-Cff ion-lock 1 in surfactant lipids showed enhanced α-helix
(at ∼1653 cm−1) and low β-sheet (at ∼1630 cm−1) (Fig. 2A). Deconvolution of these
SP-Cffion-lock1spectraverifiedthatthemajorstructuralcomponentinlipidswasα-helix
(∼44.6%),producedbyaconformationalchangefromtheveryhighβ-sheet(∼74.3%)of
its parent SP-Cff (Fig. 2A; Table 1). Incorporation of the ion-pair (i.e., Glu−-20–Lys+-24)
inducedasimilarconformationalshiftforSP-Cffinthelipid-mimicHFIPsolutionfroma
β-sheetconformation(∼53.2%)toonethatispredominatelyα-helix(∼53.0%)(Table2).
Although these FTIR spectral results suggest at least a partial salt-bridge for SP-Cff ion-
lock 1 in lipid and lipid-mimic environments, additional FTIR experiments indicate that
thissalt-bridgemaynotbeasstableasthatseenwithSP-Cssion-lock1.UnlikeSP-Cssion-
lock1,SP-Cffion-lock1foldsprimarilyasloop-turnsinaqueousbuffer(Table2)andeven
shows diminished α-helix content in surfactant lipids relative to that of SP-Css ion-lock 1
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 14/42(i.e., ∼44.6 vs. ∼63.1% in Fig. 2A and Table 1). Such α-helical reductions may be partially
due to the Phe groups of SP-Cff ion-lock 1 (Fig. 1) weakening the putative salt-bridge
betweenGlu−-20–Lys+-24,eitherthroughdirectorindirectmechanisms(seebelow).
It is also worthwhile to contrast the helical properties determined for FTIR spectra
of SP-Css ion-lock 1 and SP-Cff ion-lock 1 with those of SP-C33 UCLA and several
SP-C33 ion-locks. SP-C33 UCLA has the same sequence as SP-C33 (Almlen et al.,
2010; Almlen et al., 2011) with poly-Leu substituting for the poly-Val in the C-terminal
region (Fig. 1). Previous CD and FTIR studies have reported that SP-C mimics of the
poly-Leu class, including SP-C33 (Almlen et al., 2011) and its homologous precursor
SP-C(Leu) (Nilsson etal., 1998), eachshow elevatedα-helix whenincorporated intolipids
or lipid-mimics. In support of these experimental results, earlier Molecular Dynamics
simulations of SP-C33 in methanol for 10 ns indicated that the hydrophobic poly-Leu
region adopted an α-helical conformation in this membrane-interfacial mimic (Almlen
et al., 2010). The FTIR spectrum of SP-C33 UCLA in surfactant lipids overlapped that
of SP-Css ion-lock 1 (Figs. 2A and 2B), and spectral deconvolution indicated similarly
high α-helix (Table 1). Moreover, FTIR spectra of SP-C33 UCLA in either aqueous or
HFIP solutions showed α-helical components (at ∼1653–1655 cm−1) nearly identical to
those of SP-Css ion-lock 1 (not shown), as well as similar α-helix levels (i.e., ∼40%–51%)
using spectral deconvolution (Table 2). Although SP-Css ion-lock 1 and SP-C33 UCLA
indicate comparably high α-helix in aqueous buffer, aqueous HFIP buffer or surfactant
lipids(Fig.2:Tables1and2),SP-C33UCLArequiresreplacementofthepoly-Valsequence
with ten Leu residues to achieve this stabilization. Contrarily, SP-Css ion-lock 1 needs
only a single ion-pair at Glu−-20–Lys+-24 to maintain high α-helix. In further research,
the SP-C33 ion-lock 1 and SP-C33 ion-lock 2 mimics were prepared by inserting a
single (i.e., Glu−-20–Lys+-24) or double (i.e., Lys+-15–Glu−-19 and Glu−-20–Lys+-24)
ion-lock into the SP-C33 sequence (Fig. 1). FTIR spectra and deconvolution indicated
α-helix for these SP-C33 ion-locks in aqueous, HFIP-water and surfactant lipids similar
to those of SP-C33 (Fig. 2; Tables 1 and 2). For example, the FTIR spectra of SP-C33
UCLA and the SP-C33 ion-locks in surfactant lipids nearly overlap with α-helix maxima
at 1655 cm−1 (Fig. 2B), and spectral deconvolutions of each show elevated α-helix of
∼65%–67% (Table 1). Because the insertions of either one or two charged ion-pairs
were unable to raise the α-helical content beyond that of the parent SP-C33 UCLA
(Tables 1 and 2), the SP-C33 primary sequence may already be maximized for α-helix.
Interestingly, the α-helicity of SP-Css ion-lock 1 in surfactant lipids (i.e., ∼63%) is only
slightlybelowthoseoftheSP-C33andtheSP-C33ion-locks(i.e.,∼65%–67%),suggesting
thattheSP-Cssion-lock1inlipidsisalsoalmostoptimizedforα-helix.
Effects of ion-locks on the aggregation domains of SP-C peptides
detected with PASTA analysis
PASTA calculations were next performed to assess whether the enhanced α-helicity in-
ducedbyion-lockinsertionintoeitherSP-CssorSP-Cff(Fig.2;Tables1and2)isrelatedto
thedisruptionofβ-sheetregionsinthehostpeptides.ThePASTAalgorithmsystematically
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 15/42Figure 3 Plot of α-helix (%) from FTIR spectra of SP-C peptides in surfactant lipids versus relative
PASTA energies. Percent (%) α-helix was determined from the FTIR spectra of SP-Css, SP-Cff, SP-Css
ion-lock 1, SP-Cff ion-lock 1, SP-C33 UCLA, SP-C33 ion-lock 1 and SP-C33 ion-lock 2 (Fig. 2; Table 1).
Relative energy values were from PASTA, with less negative values reflecting a lower propensity to form
β-sheet. The PASTA energies for SP-Css, SP-Cff, SP-Css ion-lock 1 and SP-Cff ion-lock 1 are calculated
from the C-terminal residues 7–27, while those from SP-C33, SP-C33 ion-lock 1 and SP-C33 ion-lock 2
are from the C-terminal segment 6–26. The sequences and numbering for the SP-C peptides are in Fig. 1.
determines the relative energies for various paired sequences by assessing an energy
function for facing residues that are H-bonded within a β-sheet (Trovato et al., 2006).
Here, PASTA predicted that the native SP-Cff and SP-Css peptides will each form β-sheet
at their respective C-terminal domains. Specifically, PASTA energy calculations showed
that the most likely pairing for SP-Cff or SP-Css will be an interpeptide, parallel β-sheet
(i.e., parallel in-register arrangement (PIRA)) for the C-terminal residues 7–27 (Fig. 1)
with arelative PASTAenergy of−29.2 (Trovato etal., 2006;Trovato, Seno& Tosatto,2007).
Usingadatabaseof179peptidesasabenchmark(Trovato,Seno&Tosatto,2007),anenergy
threshold of <−29.0 indicates a probability >98% (true positive rate) that SP-Cff and
SP-Css are each “amyloid-like” (i.e., have a high β-sheet tendency) for the corresponding
C-terminal segments (i.e., residues 7–27). This prediction of elevated β-sheet for SP-Css
and SP-Cff was confirmed by FTIR spectra of these peptides in surfactant lipids with
high β-sheet and low α-helix (Figs. 2 and 3; Table 1). Furthermore, Fig. 3 shows that
incorporationofGlu−-20–Lys+-24ineitherSP-CfforSP-CssincreasedtherelativePASTA
energy from −29.2 to −22.2 for the 7–27 sequence, and also raised the α-helix levels of
the particular SP-C ion-locks in surfactant lipids. Because FTIR deconvolutions (Fig. 2;
Table1)demonstratedthattheenhancedα-helixinSP-Cssion-lock1orSP-Cffion-lock1
inlipidsoccurredconcomitantlywithreducedβ-sheet,thechargedion-pairmaypartially
augmentα-helicitybydisruptingβ-sheetintheC-terminalregion.
Interestingly, Fig. 3 shows that an analogous insertion of ion-locks in SP-C33 does
not increase the α-helix levels of SP-C33 ion-lock 1 and SP-C33 ion-lock 2 in surfactant
lipids, despite the relative PASTA energies for these daughter ion-locks being substantially
higher than that of the parent SP-C33. The inability of ion-locks to further raise the
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into SP-Css and SP-Cff, may be due to the already high α-helix and low β-sheet present in
the SP-C33 peptide (Fig. 3). FTIR spectral deconvolutions for SP-C33, SP-C33 ion-lock 1
and SP-C33 ion-lock 2 in surfactant lipids each indicated <∼8%β-sheet (Table 1), and
additional recruitment of α-helix from β-sheet residues may not be possible. In this
context,SP-Cssion-lock1insurfactantlipidsmaybesimilarlyoptimizedforhighα-helix,
as FTIR deconvolutions showed elevated α-helix and diminished β-sheet matching those
ofSP-C33andSP-C33ion-locks(Table1).
Prediction of transmembrane α-helices for SP-C mimics using
MPEx hydropathy calculations
Because secondary structure analysis using FTIR spectroscopy or PASTA do not directly
measure membrane binding of helical peptides, the tendency of SP-C peptides to
form transmembrane α-helices was next evaluated with hydropathy calculations using
the Membrane Protein Explorer (MPEx) program. MPEx determines the hydropathy
(kcal/mol) for protein sequences using the augmented Wimley-White (WW) hy-
drophobicity scale and is based on measurements of the partitioning of hydrophobic
pentapeptides and salt-bridge pairs into n-octanol (Jayasinghe, Hristova & White, 2001).
Previous MPEx calculations have predicted transmembrane helices for protein sequences
with high accuracy and are especially useful in preliminary characterizations of novel
proteins or peptides (Snider et al., 2009; Liang et al., 2012). One important feature of
MPExisitsoptionforengagingpotentialsalt-bridgesusingan“enter-remove”icononthe
control panel (Snider et al., 2009). However, note that dipalmitoylated SP-C is excluded
from the below comparisons, because the MPEx and PASTA algorithms do not correct for
how covalently attached, non-peptide moieties (e.g., the palmitoyl groups in native SP-C;
Fig.1)maymodifymembraneincorporationorpeptideaggregation,orboth.
As a surrogate for native SP-C, the rSP-C sequence was submitted to MPEx, which
predicted that this SP-C mimic would insert into lipid bilayers as a transmembrane
α-helix with its most favorable hydropathy (i.e., 11.3 kcal/mol) through the C-terminal
segment 12–30. The rSP-C sequence was chosen as a control for our MPEx analyses
of SP-C ion-locks, because the recombinant protein is highly homologous with the
dipalmitoylated SP-C (Fig. 1), lacks the two palmitoylcysteine groups of the native
protein and has been previously subjected to structural and functional experiments. To
simultaneously visualize the respective propensities of SP-C peptides to insert into lipids
as transmembrane helix and to form β-sheet, the “Hydropathy from MPEx” (ordinate) is
plotted versus the “Relative PASTA Energy” (abscissa) for various SP-C mimics (Fig. 4).
The more positive hydropathy values (i.e., bottom-to-top) reflect greater incorporation
as a transmembrane helix, while higher relative PASTA energy values (i.e., left-to-right)
represent a lower tendency to form β-sheet. If rSP-C binds to lipid bilayers with the same
helical conformation as in chloroform-methanol (i.e., α-helix for residues 9–34) (Luy
et al., 2004), then Fig. 4 predicts that rSP-C readily incorporates as a transmembrane
α-helix through its C-terminus. The very low PASTA energy indicated for rSP-C (Fig. 4)
may also be responsible for the metastable helical properties observed in earlier 2D-NMR
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 17/42Figure 4 Plot of hydropathy (kcal/mol) vs. relative PASTA energy values, determined for the rSP-
C, SP-Css ion-lock 1, SP-C33 and SP-C33 ion-lock 1 and SP-C33 ion-lock 2 peptides. Hydropathy
(kcal/mol) is a measure of the hydrophobic partitioning for helical peptides into transmembrane en-
vironments, determined using MPEx. Positive hydropathy predicts elevated lipid binding for helical
peptides, while more negative values forecast greater water-solubility. Relative energy values were from
PASTA, with less negative values reflecting a lower propensity to form β-sheet. Top-left quadrant: The
rSP-C (filled circle) and SP-Css ion-lock 1 (open circles) values are shown. The PASTA energies for rSP-C
and SP-Css ion-lock 1 are calculated from the respective segments 7–27, while MPEx hydropathies are
determined from the respective segments 12–30. The SP-Css ion-lock 1 value, connected to the rSP-C
value by a solid line, reflects the hydropathy for an α-helical peptide with an engaged salt-bridge (i.e.,
close-range) between Glu−–Lys+. Alternatively, the SP-Css ion-lock 1 value, connected to the SP-C
value by a dashed line, indicates a hydropathy with a disengaged salt-bridge (i.e., long-range). The SP-Cff
ion-lock 1 values overlap those of SP-Css ion-lock 1. SP-Css and SP-Cff points are not included, because
MPEx does not accurately predict the transmembrane insertion of such short helices (i.e., ≤∼8 residues)
(Table 1). Top-right quadrant: The SP-C33 (filled inverted triangles) and SP-C33 ion-lock 1 and 2 (open
inverted triangles) values are shown. The PASTA energies for SP-C33, SP-C33 ion-lock 1 and SP-C33
ion-lock 2 are each calculated from the C-terminal segment 6–26, while MPEx hydropathy is determined
from each 13–31 segment. The SP-C33 ion-lock values, connected to the parent SP-C33 value by a solid
line, reflect the hydropathies of α-helical peptides with engaged salt-bridges between the Glu−–Lys+
pair. Alternatively, the SP-C33 ion-lock values, connected to the SP-C33 value by dashed lines, indicate
hydropathies with disengaged salt-bridges between the Glu−–Lys+ pairs. See Fig. 1 for sequences.
studies(Luyetal.,2004),asβ-sheetmultimersorfibrilsshouldherebethermodynamically
favoredoverα-helix(Fig.3)(Trovatoetal.,2006;Trovato,Seno&Tosatto,2007).
TherelativetendenciesofSP-Cssion-lock1andSP-Cffion-lock1topenetrateintolipid
bilayers as transmembrane α-helices were also predicted with the joint MPEx and PASTA
plot in Fig. 4. Earlier MPEx research showed that hydrophobic helices bearing salt-bridges
may penetrate deeply into lipid bilayers, because there is only a slight thermodynamic
penalty for replacing the hydrophobic residues of a transmembrane sequence with a
neutral, charged ion-pair (e.g., Glu− and Lys+) (Snider et al., 2009; Jayasinghe, Hristova &
White,2001).Moreover,previouselectrostaticcalculationsindicatedthatsalt-bridgeswith
close-range distances (≤4.0 ˚ A) between the cationic residue “N” and the nearest anionic
residue “O” are mostly α-helix stabilizing, while disengaged salt-bridges with long-range
distances (>5 ˚ A) may be helix destabilizing (Kumar & Nussinov, 1999; Kumar & Nussinov,
2002). As indicated above, MPEx allows hydropathic analysis of SP-C ion-lock sequences
in membranes assuming the salt-bridge is either engaged (i.e., close-range salt-bridge)
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 18/42or disengaged (i.e., long-range salt-bridge). With a close-range salt-bridge between the
Glu−-20–Lys+-24 pair, MPEx forecasts that a highly α-helical SP-Css ion-lock 1 would
deeplyembedinto thelipidbilayerdue tothehigh hydropathy(i.e.,∼10.3kcal/mol)of its
segment12–30.Alternatively,withalong-rangesalt-bridgebetweenGlu−-20–Lys+-24,the
corresponding MPEx hydropathy would be much lower (i.e., ∼4.0 kcal/mol) and predicts
a more superficial association between a less helical SP-Css ion-lock 1 and the bilayer.
Our FTIR results indicating high α-helicity for SP-Css ion-lock 1 in surfactant lipids are
consistent with a close-range salt-bridge forming in this environment, permitting deep
insertionofthisSP-Cmimicasatransmembraneα-helix.Specifically,FTIRdeconvolution
in Table 1 showed that an SP-Css ion-lock 1 in surfactant lipids is highly α-helical
(∼63.1%). Thus, the SP-Css ion-lock 1 α-helix (∼21 residues) may span the width of
the bilayer, as it lies within the 17–25 residue window reported for other transmembrane
α-helices (Liang et al., 2012). The PASTA prediction that the Glu−-20–Lys+-24 pair
in SP-Css ion-lock 1 converts segment 7–27 from β-sheet to α-helix (Figs. 3 and 4)
also supports the MPEx assignment that α-helix is confined to the C-terminal region.
Consequently, helical SP-Css ion-lock 1 with a close-range salt-bridge shows a high
hydropathy, which is only slightly less than that of rSP-C (i.e., 10.3 vs. 11.3 kcal/mol in
Fig. 4), and should mimic the transmembrane incorporation of native SP-C peptides. On
theotherhand,thereducedα-helicityobservedforSP-Cffion-lock1insurfactantlipidsis
compatiblewithadisruptive,long-rangesalt-bridgethatlowersα-helicallevelsto∼44.6%
(Table 1). The resulting SP-Cff ion-lock 1 α-helix is too short (∼15 residues) to span the
width of the bilayer (Liang et al., 2012) and instead may be limited to a single monolayer.
These studies suggest that the replacement of the two serines in SP-Css ion-lock 1 with
vicinal phenylalanines disorders the close-range, salt-bridge between Glu−-20–Lys+-24,
througheitherdirectorindirectmechanisms.
FTIR secondary structure and theoretical analyses similarly examined the insertion of
SP-C33mimicsintothelipidbilayerastransmembraneα-helices.Figure4indicateshigher
MPEx and PASTA energy values for SP-C33 relative to those of rSP-C, predicting that the
swap of poly-Leu with the poly-Val sequence of native SP-C produces an SP-C33 mimic
that associates with lipids as a transmembrane α-helix. In support of this assignment,
FTIR showed that the principal spectral component for SP-C33 UCLA in surfactant lipids
was α-helix and that the α-helicity (67.2% from Table 1) for SP-C33 UCLA is sufficiently
highforthis SP-Cmimictoincorporateas atransmembranehelix(∼22residueslong). In
this context, Fig. 4 also predicts that SP-C33 ion-lock 1 or SP-C33 ion-lock 2 (i.e., SP-C33
mimicswithoneortwoGlu−-20–Lys+-24pairs;Fig.1)willincorporateintolipidbilayers
either as transmembrane α-helices with close-range salt-bridges or disordered α-helices
with long-range salt-bridges and reduced membrane affinity. Because our FTIR results
show only high α-helix levels for these SP-C33 ion-locks matching those of the parent
SP-C33 in surfactant lipids (Table 1), both SP-C33 ion-lock 1 and SP-C33 ion-lock 2 will
likely form engaged salt-bridges, and incorporate into surfactant lipids as transmembrane
α-helices.
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mimics in surfactant lipids
The topography of helical SP-C mimics in surfactant lipid multilayers was experimentally
assessedbyrecordingpolarizedinfraredspectraofeachlipid-peptidefilmthatwasrotated
from 0◦ to 90◦. Orientation-dependent FTIR spectroscopy of native SP-C (Vandenbussche
et al., 1992; Pastrana, Maulone & Mendelsohn, 1991) and unrelated membrane proteins
(Chia et al., 2002; Beevers & Kukol, 2006) was previously used to determine the Θ
angles between their respective helical axes and the normal to the lipid bilayer plane.
Early polarized FTIR studies indicated that native bovine and porcine SP-C proteins
(Vandenbussche et al., 1992; Pastrana, Maulone & Mendelsohn, 1991) each insert into
surfactant lipids as a transmembrane helix whose long molecular axis parallels the
phospholipid acyl chains and a maximum angle of ∼20–24◦ with respect to the bilayer
normal.Inthepresentresearch,thepolarizedFTIRspectraoftheamideIbandforSP-Css
ion-lock1insurfactantmultilayerswerehighlyanisotropic,withhighandlowabsorbance
at0◦ and90◦ (Fig.5A). ThedichroicratioRfor SP-Cssion-lock1is computedastheratio
of the integrated amide I absorption at parallel and perpendicular with polarized infrared
light. The use of this dichroic R indicated a maximum tilt angle Θ = 22.6◦ for the helical
axis of SP-Css ion-lock 1 with respect to the bilayer normal (Table 1), similar to those
determined previously for native SP-C (Vandenbussche et al., 1992; Pastrana, Maulone &
Mendelsohn, 1991). Based on its high α-helicity (63.1%) (Fig. 2A; Table 1), the SP-Css
ion-lock 1 probably incorporates in surfactant lipids as a transmembrane α-helix (∼21
residues long) spanning the bilayer with a maximum 22.6◦ tilt, particularly if this SP-C
mimicishighlyhydropathicduetoasalt-bridgebetweenGlu−-20–Lys+-24(Fig.4).When
comparedwithFTIRresultsfromSP-Cssion-lock1ornativeSP-C,however,thepolarized
FTIR spectra for SP-Cff ion-lock 1 in surfactant lipids were less anisotropic with a lower
dichroic R and demonstrated a correspondingly higher maximum tilt angle (Θ = 34.2◦)
(Table 1). Because of its reduced α-helix levels (∼44.6%) calculated from FTIR spectral
deconvolutions and higher maximum tilt angle (Figs. 2A and 5B; Table 1), the relatively
short (∼15 residues) α-helix of SP-Cff ion-lock 1 in surfactant lipids is probably limited
to one bilayer leaflet. One hypothesis worth exploring is that the low α-helicity and more
oblique Θ observed for SP-Cff ion-lock is due to a failure of its Glu−-20–Lys+-24 to form
anengagedsalt-bridge(i.e.,close-range)insurfactantlipids.
Analogous oriented FTIR experiments were performed to characterize the membrane
topography of SP-C33 and SP-C33 ion-locks in surfactant lipids. As noted above,
conventional FTIR analysis of SP-C33 UCLA, SP-C33 ion-lock 1 or SP-C33 ion-lock 2
(Fig.1)insurfactantlipidseachshowedspectrawithapredominantα-helixbandcentered
at 1655 cm−1 (Fig. 2B) and elevated levels (65%–67%) of α-helix (Table 1). The polarized
FTIR spectra of the amide I bands for SP-C33 UCLA (Fig. 5D), SP-C33 ion-lock 1
(Fig. 5C) and SP-C33 ion-lock 2 (not shown) were all highly anisotropic, indicating
maximum Θ angles of ∼23◦ (Table 1). Consequently, SP-C33 UCLA and the SP-C33
ion-locks incorporate into surfactant lipid as transmembrane α-helices (∼21–22 residues
long) spanning the bilayer with a maximum tilt angle of ∼23◦, confirming that they
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 20/42Figure 5 ATR-FTIR polarized spectra of the amide I band for synthetic SP-C peptide mimics in
oriented DPPC:POPC:POPG (5:3:2) bilayers with 10 mM deuterated phosphate buffer (pD 7.4). The
bottom spectra in each plate were recorded with parallel (para; solid line) and perpendicular (perp;
dashed line) polarized light with respect to the incident plane. The dichroic spectra at top in each plate
is the difference between the spectrum recorded with parallel polarized light from that obtained with
perpendicular polarized light. Recorded and subtracted spectra for each SP-C peptide are drawn using
the same ordinate scale. (A) SP-Css ion-lock 1. (B) SP-Cff ion-lock 1. (C) SP-C33 ion-lock 1. (D) SP-C33
UCLA. See Fig. 1 for SP-C mimic sequences.
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et al., 1992; Pastrana, Maulone & Mendelsohn, 1991). Moreover, SP-C33 ion-lock 1
and SP-C33 ion-lock 2 each probably contain stable salt-bridges as predicted from
MPEx-hydropathy analysis (Fig. 4; top right quadrant), which would facilitate the deep
penetration of these SP-C mimics into surfactant bilayers. Importantly, our orientation-
dependent FTIR results with SP-C33 UCLA (Fig. 5D; Table 1) are in good agreement with
those earlier reported for SP-C33 incorporated into surfactant lipid bilayers (Almlen et al.,
2011), despite these studies using different experimental conditions for peptide synthesis
andFTIRspectralmeasurements.
FTIR analysis of hydrogen/deuterium (H/D) exchange for amide
protons of SP-C mimics in surfactant lipids
For selected SP-C mimics with surfactant lipids, the extent of peptide helix insertion
into the lipid bilayer was characterized by measuring the hydrogen/deuterium (H/D)
exchange of amide protons. Previous studies of native SP-C (Vandenbussche et al., 1992;
Pastrana, Maulone & Mendelsohn, 1991) and unrelated membrane proteins (Chia et al.,
2002; Grimard et al., 2001) indicated that protons participating in the H-bonds of highly
ordered structures such as the transmembrane α-helix may show a lack of deuterium
exchange for up to 6–28 h. The H/D exchange for amide protons that maintain the
transmembrane α-helix was assessed as follows. SP-C mimic-lipid samples on the ATR
crystalwerehydratedbybubblingnitrogenthrougha10mMdeuteratedphosphatebuffer
(pD 7.4) at 37 ◦C, and the amide I and amide II peaks were recorded with FTIR spectra
over the range 1500–1700 cm−1 as a function of time (0–6 h). The peak between 1600
and 1700 cm−1 reflects the amide I band (i.e., ν (C=O) of the peptide bond) that is
sensitive to the secondary conformations of the protein, while the second band between
1525 and 1565 cm−1 is primarily due to amide II (i.e., δ (N–H) of the peptide bond)
(Vandenbussche et al., 1992; Jackson & Mantsch, 1995). The ratio of the amide II to amide
I peak areas is proportional to the H/D exchange, as such exchange would shift the amide
II band (at ∼1543 cm−1) to that of amide II’ (at ∼1450 cm−1) (Pastrana, Maulone &
Mendelsohn, 1991). Contrarily, the absence of H/D exchange would suggest that the
H-bonds are isolated from aqueous media (e.g., transmembrane α-helices), or are in
aqueousenvironmentsinorderedconformationswhereexchangeisslow.
In Fig. 6 the percentage (%) unexchanged hydrogens for the SP-Css ion-lock 1
in surfactant lipids is shown as a function of time (0–6). Analogous H/D curves for
membrane proteins were previously analyzed as the sum of multiple linear exponential
(first-order) decays (Grimard et al., 2001). Besides fast- and intermediate-H/D exchange
compartments (i.e., with t1/2’s between 10 and 120 min involving ∼49% of the helical
residues), there is a final compartment for helical amide hydrogens (∼51%) that resists
H/D exchange for t ≤ 6 h (Fig. 6). The inaccessible fraction at long-times is probably
due to segments buried deeply as transmembrane α-helix, as the residual amide II band
remains centered at ∼1543 cm−1 (not shown). Because spectral deconvolutions indicated
∼21 α-helical residues for SP-Css ion-lock 1 in surfactant lipids (Table 1), ∼11 α-helical
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 22/42Figure 6 The percent (%) unexchanged hydrogens vs. time (min) from FTIR of SP-C mimics in
surfactant lipids. SP-Css ion-lock 1 (inverted triangle, green), SP-C33 UCLA (square, magenta) and
SP-Cff ion-lock 1 (hex, blue) were each incorporated into DPPC:POPC:POPG (5:3:2, weight ratio), and
the peptide-lipid sample on the ATR crystal was initially hydrated by bubbling nitrogen through a 10
mM deuterated phosphate buffer (pD 7.4) at 37◦C. The time-dependent H/D exchange of the amide
group was determined from the decay of the amide II band area (1525–1565 cm−1) with respect to the
corresponding amide I band area (∼1600–1700 cm−1) as a function of time (0–6 h).
residues are readily calculated as unexchanged for this SP-C mimic at long-times (Almlen
etal.,2011;Beevers&Kukol,2006).Importantly,similarH/Dexchangekineticswasearlier
reported for bovine and porcine SP-C (Vandenbussche et al., 1992; Pastrana, Maulone &
Mendelsohn, 1991), indicating that SP-Css ion-lock 1 is accurately mimicking the ability
of native SP-C proteins to embed into surfactant lipids as transmembrane α-helices. In
additional studies, the kinetic H/D exchange profile for SP-Css ion-lock 1 was nearly
identical to that of SP-C33 UCLA (Fig. 6), and very similar to that reported earlier for the
conventional SP-C33 (Almlen et al., 2011). The comparable H/D exchange and maximum
tilt angles observed for SP-Css ion-lock 1, SP-C33 UCLA and SP-C33 (Figs. 5 and 6;
Table 1) (Almlen et al., 2011) indicate that these three SP-C mimics similarly incorporate
into surfactant lipids as transmembrane α-helices. Interestingly, the H/D curve for SP-Cff
ion-lock 1 in Fig. 6 demonstrates both similarities and differences with those of SP-Css
ion-lock 1 and SP-C33 UCLA. Despite SP-Cff ion-lock 1 showing fast-, intermediate- and
veryslow-exchangecompartmentsanalogoustothoseoftheothertwoSP-Cmimics,there
wasoverallamorerapidH/DexchangeforSP-Cffion-lock1inFig.6.Thesediscrepancies
wereparticularlynoticeableat6h,whentheunexchangedhydrogencomponentforSP-Cff
ion-lock 1 was ∼23.2%, while those for SP-Css ion-lock 1 and SP-C33 UCLA were each
∼51% (Fig. 6). Consequently, only ∼3.5 helical residues of SP-Cff ion-lock 1 showed
unexchanged hydrogen at long-times in Fig. 6, compared to the ∼11 helical residues that
remain unexchanged in either SP-Css ion-lock 1 or SP-C33 UCLA. The sharply lower
unexchanged helical protons for SP-Cff ion-lock 1 in surfactant lipids (Fig. 6) may be due
to a more flexible membrane α-helical component or increased accessibility of helical
amidehydrogenstotheaqueousmedium.
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 23/42Figure 7 Adsorption of synthetic surfactant compositions containing SP-Cff, SP-C33 and SP-C ion-
lock mimics plus synthetic phospholipids (5:3:2 weight ratio DPPC:POPC:POPG). Adsorption was
measured as Adsorption Surface Pressure (mN/m), following injection of a surfactant bolus beneath the
interface of a stirred subphase at time zero. Surface pressure is the amount of surface tension lowering
belowthatofthepuresubphase(normalsalineadjustedtopH7.0)at37±0.5◦C.Highersurfacepressure
equates to lower surface tension. Surfactant concentration was 0.0625 mg phospholipid/ml of subphase.
Data are Means ± SEM for n = 4. Sequences for SP-Cff, SP-Css ion-lock 1, SP-Cff ion-lock 1, SP-C33
ion-lock 2 and SP-C33 UCLA are given in Fig. 1.
In vitro surface activity determined with adsorption surface pres-
sure measurements
Synthetic surfactant preparations were formulated by mixing synthetic lipids (Lipids)
consisting of 5:3:2 (weight ratio) DPPC:POPC:POPG, with 3.0% by weight SP-Css
ion-lock 1, SP-Cff ion-lock 1, SP-Cff, SP-C33 ion-lock 1, SP-C33 UCLA (positive control)
andLipids(negativecontrol).Here,adsorptionwasdeterminedastheAdsorptionSurface
Pressure(mN/m)asafunctionoftime(0–15min),withhighersurfacepressuresreflecting
lower surface tensions. The time-course plots in Fig. 7 indicate that each of these SP-C
mimics attained maximal adsorption surface pressure within ∼5–10 min. The relative
order for the surfactant activities of the various preparations was as follows: SP-C33
ion-lock 2 ≥ SP-Css ion-lock 1, SP-C33 UCLA ≫ SP-Cff ion-lock 1 ∼ SP-Cff > Lipids.
Previous in vitro studies on SP-C(Leu), a homologous precursor to our SP-C33 UCLA,
with a lipid mixture of DPPC/POPG (7:3 ratio by mass) showed similarly enhanced
adsorptionsurfacepressurecurves(Nilssonetal.,1998).
In vitro dynamic surface activity determined with captive bubble
surfactometry
Syntheticsurfactantformulationswerealsopreparedforin vitroexperimentswithcaptive
bubble surfactometry and in vivo studies using ventilated, lung-lavage rabbits by mixing
syntheticlipids (Lipids),consisting of5:3:2 (weightratio) DPPC:POPC:POPG,with3.0%
by weight SP-Css ion-lock 1, SP-Cffion-lock 1, SP-C33 ion-lock 1, SP-Cff, SP-Css, SP-C33
UCLA (positive control) and Lipids (negative control). The SP-Css ion-lock 1 surfactant
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 24/42Figure 8 Surface activity of synthetic surfactants on the captive bubble surfactometer. Minimum and
maximum surface tension values are plotted for synthetic lipids (Lipids) with 3.0% by weight SP-Cff,
SP-Css, SP-Css ion-lock 1, SP-C33 ion-lock 1, SP-Cff ion-lock 1 and SP-C33 UCLA (positive control)
or synthetic lipids alone (negative control) for 10 successive compression cycles on a captive bubble
surfactometer (20 cycles/min, 37◦C). Synthetic lipids = 5:3:2 (weight ratio) DPPC:POPC:POPG. Values
shown are means with estimated SEM, for n = 4–6. See Fig. 1 for SP-C mimic sequences.
hadveryhighsurfaceactivityincaptivebubbleexperimentsandreachedminimumsurface
tension values <1 mN/m during each of ten consecutive cycles of dynamic cycling (rate
of 20 cycles/min, Fig. 8). Importantly, our SP-C33 UCLA (positive control) attained low
surfacetensionvalues<1mN/mthatnotonlywereidenticaltothoseofSP-Cssion-lock1
(Fig. 8), but also matched those of SP-C33 in earlier captive bubble experiments with
DPPC/POPGlipidmixtures.TheSP-C33ion-lock1surfactantexertedsimilarlowsurface
tensions as SP-C33 UCLA. Contrarily, SP-Cff ion-lock 1, Lipids (negative control), SP-Cff
and SP-Css all reached significantly higher minimum surface tension values of 19, 16, 11
and 14 mN/m (p < 0.001) versus SP-Css ion-lock 1 and SP-C33 UCLA after ten cycles on
thecaptivebubblesurfactometer(Fig.8).Insummary,therelativeorderforthesurfactant
activities determined with captive bubble surfactometry for the various preparations was
asfollows:SP-Cssion-lock1 ∼SP-C33UCLA∼SP-C33ion-lock1≫SP-Cff∼SP-Css≫
Lipids∼SP-Cffion-lock1.
In vivo activity of synthetic surfactants in ventilated, lung-lavaged,
surfactant-deficient rabbits
The pulmonary activity of SP-C mimic surfactants (described above for captive bubble
experiments) was investigated in comparison to SP-C33 UCLA (positive control)
and Lipids alone (negative control) during a 120 min period following intratracheal
instillation of these surfactants into ventilated rabbits with ARDS induced by in vivo
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 25/42Figure 9 Arterial oxygenation and dynamic compliance in surfactant-treated, ventilated rabbits with
ARDS induced by in vivo lavage. (A) Arterial partial pressure of oxygen (PaO2 in torr) shown as a
function of time for groups of at least 4 rabbits treated with synthetic lung surfactants containing
synthetic lipids with 3.0% by weight SP-Cff, SP-Css ion-lock 1, SP-C33 ion-lock 1, SP-Cff ion-lock 1,
and SP-C33 UCLA (positive control), or synthetic lipids alone (negative control). Synthetic lipids are
DPPC:POPC:POPG (5:3:2, weight ratio). (B) Dynamic compliance (mL/kg/cm H2O) shown as a func-
tion of time for groups of at least 4 rabbits treated with the same lung surfactant preparations as shown
in (A). Data are shown as means ± SEM, for n = 4–7. Sequences for SP-C mimics are shown in Fig. 1.
lavage (Fig. 9). Oxygenation and lung compliance increased quickly to a plateau phase
(within ∼30–60 min) after instillation of SP-Css ion-lock 1 and SP-C33 UCLA, with
SP-C33 ion-lock 1 reaching similarly high functional plateaus after somewhat longer
times (within ∼60 min) (Fig. 9). On the other hand, the SP-C mimics SP-Cff and SP-Cff
ion-lock 1 restored more slowly (within ∼90 min) and only partially the oxygenation
and dynamic compliance observed with SP-Css ion-lock 1 and SP-C33 UCLA. The
corresponding oxygenation and dynamic compliance curves obtained for SP-Css (not
shown for clarity) overlapped those of SP-Cff in Fig. 9. Last, instillation of the negative
control of Lipids alone had minimal effects on arterial oxygenation or compliance.
The relative order of pulmonary activity in terms of both oxygenation and compliance
(≥90 min) was given as: SP-Css ion-lock 1 ∼ SP-C33 UCLA (positive control) ∼ SP-C33
ion-lock 1 ≫ SP-Cff ∼ SP-Css > SP-Cff ion-lock 1 ≫ Lipids (negative control). Although
the differences in oxygenation and compliance between SP-Css ion-lock 1, SP-C33
UCLA and SP-C33 ion-lock 1 were not statistically significant starting at 90 min after
surfactantinstillation,eachoftheseSP-Cmimicsconsistentlyexceededthecorresponding
Walther et al. (2014), PeerJ, DOI 10.7717/peerj.485 26/42performance of SP-Cff, SP-Css, SP-Cff ion-lock 1 and lipids only surfactants (p < 0.01)
(Fig.9).
DISCUSSION
Structural and functional studies investigated first generation SP-C peptides based on
native SP-C sequences (e.g., synthetic SP-Cff and SP-Css lacking palmitoyl groups; Fig. 1),
andassessedtheirutilityasscaffoldsfornewSP-Cion-lockpeptideswithenhancedhelicity
and surfactant activities. Unlike the high α-helix observed for native dipalmitoylated
SP-C in surfactant lipids (Vandenbussche et al., 1992; Pastrana, Maulone & Mendelsohn,
1991),FTIRspectroscopyforeitherSP-CssorSP-Cffinlipidswithaqueousbuffershowed
primarily β-sheet (Fig. 2A; Table 1). Comparable β-structures also predominated for
SP-Css and S-Cff in either 100% aqueous buffer or 65% HFIP/35% aqueous buffer
(Table2),indicatingthattheseSP-Cmimicconformationsareinsensitivetothepolarityof
their environment. These FTIR spectral results are probably due to the strong parallel
β-sheet propensities predicted by the PASTA analysis for SP-Css or SP-Cff in Fig. 3.
The above findings also suggest that palmitoylcysteines in native SP-C at least partially
act as helical ‘adjuvants’ to override the β-sheet propensities of its primary sequence
(Walther et al., 2010; Conchillo-Sole et al., 2007). With this background, it was surprising
that aqueous HFIP did not substantially raise the α-helicity of SP-Css or SP-Cff over
that in aqueous buffer (Table 2), especially because HFIP is a strong helix-inducing and
stabilizing cosolvent (Hirota, Mizuno & Goto, 1997) and provides an apolar environment
that simulates lipid membranes (Crescenzi et al., 2002). HFIP protects against β-sheet
formation by “Teflon® Coating” exposed α-helices (Rajan et al., 1997; Crescenzi et al.,
2002; Roccatano et al., 2005), thereby preventing the water attack on the helical H-bonds
that are required for conversion to β-sheet. Consequently, the elevated β-sheet observed
for SP-Css and SP-Cff in aqueous HFIP (Table 2) may be due to the extraordinarily high
β-sheet propensities of these SP-C mimics (Fig. 3) outweighing the helix-promoting
actionsofHFIP.
Comparisons with previous FTIR results (Zandomeneghi et al., 2004; Cerf et al.,
2009) additionally suggest that SP-Css and SP-Cff form ‘amyloid-like’, β-sheet fibrils
in surfactant lipids, and that these fibrils may be responsible for the low surfactant
activities observed with SP-C mimics (Figs. 7–9). An earlier literature review indicated
that native β-sheet proteins typically produce FTIR spectra with maxima at frequencies
above ∼1630 cm−1, while the corresponding spectra of amyloid fibrils demonstrate
maxima at ∼1630 cm−1 and lower frequencies (Zandomeneghi et al., 2004). Following
this scheme, the FTIR spectra in Fig. 2A suggest that SP-Css and SP-Cff with lipids may
each be forming amyloidogenic fibrils. Further comparisons with FTIR analyses of the
amyloid Aβ(1–42) suggested that SP-Css or SP-Cff in lipids are producing fibrils (Cerf
et al., 2009). Under conditions that promote fibrils, FTIR spectra of Aβ(1–42) exhibited
a single peak at ∼1630 cm−1 and negligible absorption at ∼1695 cm−1, and fibrils were
assigned to Aβ(1–42) forming parallel β-sheet. Contrarily, under conditions favoring
smaller Aβ(1–42) oligomers, FTIR spectra showed a primary peak at ∼1630 cm−1 and
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attributed to Aβ(1–42) oligomers folding like antiparallel β-sheet (Cerf et al., 2009).
Because the FTIR spectra of SP-Css and SP-Cff in surfactant lipid (Fig. 2A) are most
comparabletothoseoffibrillarAβ(1–42)(Cerfetal.,2009),ourSP-Cmimicsinsurfactant
lipids may similarly adopt parallel β-sheet, fibril structures. This assignment agrees
with PASTA predictions that the C-terminal regions of SP-Css and SP-Cff have high
parallel β-sheet propensities (Figs. 3 and 4). Moreover, prior experiments indicate that
the homologous rSP-C (Fig. 1) readily transforms from α-helical conformers to β-sheet
fibrils in lipid-mimics (Luy et al., 2004). Any β-sheet fibrils occurring in lipid mixtures of
SP-CssorSP-Cffwouldnotnecessarilybetoxicbutinsteadmayrepresentaninertpeptide
reservoir. Recent evidence with the amyloid Aβ protein demonstrates that it is only small
molecular weight oligomers, but not monomers or high molecular weight fibrils, that are
cytotoxic(Haass&Selkoe,2007;Nerelius,Fitzen&Johansson,2010).Inthiscontext,SP-Cff
and/orSP-Cssinlipidsshowedsurfactantactivitiesthatwerebetweenthoseoflipidsalone
(negative control) and those with the more active SP-C33 UCLA (positive control) (see
below and Figs. 7–9). The relatively low surfactant activities for SP-Cff and SP-Css with in
vitro (Figs. 7 and 8) and in vivo (Fig. 9) assays may be due to these SP-C mimics forming
inactivefibrilsconsistingofparallelβ-sheet,thuseffectivelyloweringtheconcentrationsof
surface-activeSP-Cpeptidesinhelicalconformations.
Because the above first generation SP-C peptides were unsuccessful in reproducing
key structural and functional properties of the native protein in surfactant lipids, a
second generation of SP-C mimics without palmitoyls is now being developed that
seeks to increase α-helicity and surfactant activities through amino acid replacements.
Previous experimental and theoretical studies indicated that SP-C embeds deeply into
lipid bilayers, in which its helical axis and covalently attached palmitoyls are nearly
parallel to the fatty acyl chains, while its cationic N-terminal region is restricted to the
polar headgroup region (see Introduction). As enhanced in vitro and in vivo surfactant
activities are highly correlated with elevated α-helix content, a biomimetic approach was
used to design α-helicity and other essential molecular features of native SP-C into new
SP-C analogs. One such class of SP-C mimics is the SP-C33 peptide, produced with the
porcine SP-C sequence as a template, in which ten valines were replaced by leucines, the
two palmitoylcysteines substituted with serines and the N-terminal arginine was moved
closer to the poly-Leu sequence (Fig. 1) (Johansson et al., 2003). This synthetic SP-C
mimic showed in vitro and in vivo surfactant activities equivalent to those of native SP-C
(Johansson et al., 2003; Almlen et al., 2011), which may be due to both SP-C33 and native
SP-Csimilarlyinsertingintosurfactantlipidswithslightlytiltedtransmembraneα-helices
(Pastrana,Maulone&Mendelsohn,1991;Vandenbusscheetal.,1992;Almlenetal.,2011).
We performed experiments here to determine whether an SP-C33 peptide with high
surfactant activity was appropriate as a positive control to benchmark the structural and
surfactantpropertiesofothersecond generationSP-Cpeptides.WithrespecttotheSP-C33
class,studieswereconductedwith‘SP-C33UCLA’,anSP-Cmimicwiththesamesequence
as SP-C33 (Fig. 1) but synthesized using a separate protocol. For example, FTIR spectra of
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buffer indicated that the predominant conformation was α-helix (Fig. 2B; Tables 1 and
2). These spectral results agree with prior findings showing high α-helix for SP-C33 in
surfactantlipidsandlipid-mimics(i.e.,methanolordetergentmicelles)usingCDorFTIR
spectroscopy (Johansson et al., 2003; Almlen et al., 2011). The enhanced α-helix levels for
SP-C33 UCLA and SP-C33 are consistent with PASTA predictions that SP-C33 sequences
(Fig. 1) have a lower propensity to form β-sheet than native SP-C peptides (Figs. 3
and 4). The total replacement of the poly-valine sequence with poly-leucine in SP-C33
UCLA suppresses ‘amyloid-like’ β-sheet structures by favoring α-helix and eliminates
the unstable conformations associated with SP-C lacking palmitoyl groups. Orientation
FTIRandH/DexchangeexperimentsindicatedthatSP-C33UCLAincorporatesintolipid
bilayers as a slightly tilted transmembrane α-helix (Figs. 5 and 6; Table 1), demonstrating
that SP-C33 UCLA accurately mimics the membrane topography of both SP-C33 (Almlen
et al., 2011) and native dipalmitoylated SP-C (Pastrana, Maulone & Mendelsohn, 1991;
Vandenbussche et al., 1992). Also supporting the above experimental results are MPEx
hydropathy predictions that SP-C33 sequences insert into membrane bilayers when
folded as α-helices (Fig. 4). In this context, note that SP-C33 UCLA demonstrated
high in vitro (Figs. 7 and 8) and in vivo (Fig. 9) surfactant activities, consistent with the
elevated surfactant activities reported earlier for SP-C33 in comparisons with commercial
preparations containing native SP-C (Johansson et al., 2003; Almlen et al., 2011). The tilted
transmembrane α-helix, identified here for SP-C33 UCLA in lipid bilayers (Figs. 5 and 6;
Table 1) and earlier for SP-C33 (Almlen et al., 2011), likely represents the surface-active
arrangement sharedby native SP-C,and departuresfrom this membranetopography may
reducesurfactantproperties.
The principal hypothesis to be tested in this paper was that the selective insertion
of salt-bridges may produce SP-C mimics that insert into lipid bilayers as slightly
tilted, transmembrane α-helices with high surfactant activity. In partial support of this
hypothesis, prior reports indicate that engaged salt-bridges (or ion-locks) in either
designer peptides or native membrane proteins promote α-helix. With CD studies of
aqueous synthetic peptides, for example, incorporation of Glu− and Lys+, Asp− and
Lys+, Asp− and Arg+ or Glu− and Arg+ spaced at (i + 4) intervals in the sequence
was helix stabilizing (Marqusee & Baldwin, 1987). This enhanced α-helicity for aqueous
peptides is at least partly due to the formation of an electrostatically neutral ion-pair
via the positive- and negative-side groups for the various amino-acid pairings (Kumar
& Nussinov, 1999; Kumar & Nussinov, 2002). Employing an augmented Wimley-White
(WW) hydrophobicity scale, MPEx analyses predicted that ‘ion-locks’ such as Glu−–Lys+
increase the helicity and lipid partitioning of peptides into membranes (Snider et al.,
2009). Additionally, continuum electrostatic calculations indicated that salt-bridges with
close distances (≤4.0 ˚ A) between the cationic residue “N” and the nearest anionic residue
“O” are mostly α-helix stabilizing, while those with correspondingly further distances
(>5.0 ˚ A) may be helix destabilizing (Kumar & Nussinov, 1999; Kumar & Nussinov, 2002).
Earlier surveys of PDB-deposited structures have reported salt-bridges with a close-range
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2002) including Ca2+-ATPase (Toyoshima et al., 2000) (PDB: 1SU4) with a membrane
helix stabilized by an intrahelical charge-pair (e.g., Asp−-59–Arg+-63) when facing lipids
(Bano-Poloetal.,2012).Importantly,ion-lockshavebeenusedinseveraldesignerpeptides
as a ‘Molecular Velcro®’ for specific purposes, such as enhancement of α-helix and
anti-HIV activity in sifuvirtide (He et al., 2008), and the trapping of otherwise unstable
structural features such as π-helix (Chapman et al., 2008) and the second β-hairpin of the
B1domainofproteinG(Huyghues-Despointesetal.,2006).
Our strategy for bioengineering new second generation SP-C mimics with high
α-helicity and surfactant properties primarily involves the introduction of Glu−–Lys+
pairings (i.e., salt-bridges or ion-locks) into SP-C sequences lacking palmitoyl groups.
With a charged ion-pair in the midsection of the parent SP-Css (Fig. 1), SP-Css ion-lock 1
in either lipids, aqueous HFIP or aqueous buffer remarkably shifted its principal confor-
mation to α-helix from amyloid-like β-sheet (Fig. 2; Tables 1 and 2). In particular, FTIR
spectraldeconvolutionsforSP-Cssion-lock1insurfactantlipidsshowedenhancedα-helix
similar to that determined for SP-C33 UCLA, our positive control SP-C peptide (i.e., 63.1
vs.66.9%,respectively;Table1).OrientedFTIRandH/DexchangeexperimentsforSP-Css
ion-lock 1 indicated a slightly tilted transmembrane α-helix in surfactant lipid bilayers
(Figs.5and6;Table1),consistentwithMPExhydropathypredictionsforthisSP-Cmimic
with a neutralized charged ion-pair (Fig. 4). A slightly tilted, transmembrane α-helix was
also identified for SP-C33 UCLA comparable to that of SP-Css ion-lock 1 (Figs. 5 and
6; Table 1). In this context, note that SP-Css ion-lock 1 showed high surfactant activities
equal to SP-C33 UCLA, as measured with in vitro adsorption surface pressure (Fig. 7)
and minimum surface tension (Fig. 8), and also with in vivo oxygenation and dynamic
compliance experiments of surfactant-treated, ventilated rabbits with ARDS (Fig. 9). One
explanationfortheenhancedactivitiesofSP-Cssion-lock1isthataclose-rangesalt-bridge
(Kumar & Nussinov, 1999; Kumar & Nussinov, 2002) forms between the Glu−-20 and
Lys+-24 residues, which promotes accurate mimicking of the high α-helicity and the
membrane topography of SP-C33 UCLA (Fig. 2; Tables 1 and 2), SP-C33 (Johansson et
al., 2003; Almlen et al., 2011) or native SP-C (Pastrana, Maulone & Mendelsohn, 1991;
Vandenbusscheet al.,1992).Analogous close-rangesalt-bridgesoccurring fortheGlu−-20
and Lys+-24 pair might also account for the high α-helix seen for SP-Css ion-lock 1 in
eitheraqueousbufferoraqueousHFIPbuffer(Table2).
Experiments next evaluated correlations between α-helicity, lipid bilayer topography
and surfactant properties for the SP-Cff ion-lock 1 mimic. Although the insertion of the
Glu−–Lys+ pairing into SP-Cff primarily converted the SP-Cff ion-lock 1 in lipids from
β-sheet to α-helix (Fig. 2A), FTIR deconvolutions of SP-Cff ion-lock 1 indicated lower
α-helix (i.e., 44.6%) than the corresponding α-helix for SP-Css ion-lock 1 (63.1%) and
SP-C33 UCLA (67.2%) (Table 1). Oriented FTIR and H/D exchange studies of SP-Cff
ion-lock 1 showed that the α-helix incorporates poorly into the lipid bilayer (Fig. 6), and
also is more tilted (34.2◦) to the membrane normal than those of either SP-Css ion-lock 1
(22.6◦) or SP-C33 UCLA (22.4◦) (Fig. 5; Table 1). Because of its shortened C-terminal
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to a single monolayer. This abnormal membrane topography may be partially due to
SP-Cff ion-lock 1 forming a disruptive, long-range salt-bridge (Kumar & Nussinov, 2002)
betweentheGlu−-20andLys+-24residues,whichwouldbeexpectedtoreducebothhelix
stability(Table1)andlipidaffinity(Fig.4).Theexposureofthechargedside-chaingroups
occurring in long-range salt-bridges (Kumar & Nussinov, 2002) may promote electrostatic
interactions between the Glu−-20 and Lys+-24 residues of SP-Cff ion-lock 1 and other
membrane components, including Lys+-24 binding to anionic phosphates in the polar
headgroupofPOPG.Suchdetergent-likepropertiesmayberesponsibleforthelowin vitro
and in vivo surfactant activities obtained for formulations containing SP-Cff ion-lock 1,
when compared with preparations containing SP-C33 UCLA, SP-Css ion-lock 1 or the
parent SP-Cff (Figs. 7–9). Interestingly, SP-Cff ion-lock 1 in aqueous buffer additionally
showed much lower α-helix and higher loop-turns than those corresponding levels
in SP-Css ion-lock 1 (Table 2), suggesting that replacement of the vicinal serines with
phenylalanines may have also produced a long-range salt-bridge that was destabilizing in
anaqueousenvironment.
In contrast to the surfactant properties of SP-Cff ion-lock 1, preparations containing
SP-C33 ion-lock 1 showed elevated surface activity using captive bubble surfactometry
(Fig.8),andalsohigharterialoxygenationanddynamiccomplianceinsurfactant-treated,
ventilated rabbits with ARDS (Fig. 9). The enhanced in vitro and in vivo surfactant
activitiesofSP-C33ion-lock1matchthoseofSP-Cssion-lock1andSP-C33UCLA(Figs.8
and 9), and are likely due to all three SP-C mimics exhibiting comparable α-helicity in
lipids(Fig.2;Table1)andincorporatingastilted,transmembraneα-helices(Figs.5and6;
Table 1). For deep insertion into lipid bilayers as a helical transmembrane α-helix, MPEx
calculationsinFig.4additionallysuggestedthatSP-C33ion-lock1willformaclose-range
salt-bridgeinthemembraneinterior.Interestingly,thiselectrostaticallyneutralion-pairis
unabletofurther increasetheα-helixcontentand surfactantactivityofSP-C33 ion-lock1
over those observed with the control SP-C33 UCLA, probably because these properties
are already optimized in the host SP-C33 UCLA peptide. Nevertheless, the presence of a
close-range salt-bridge in the mid-section of SP-C33 ion-lock 1 may improve both the
thermostability (Kumar, Tsai & Nussinov, 2000; Kumar & Nussinov, 2002) and storage
propertiesofthisSP-CmimicoverthoseofitsparentSP-C33UCLA.
Recent Molecular Dynamics (MD) simulations were also performed to assess further
whether the enhanced surfactant activities for SP-Css ion-lock 1 were due to a close-range
salt-bridge between Glu−-20 and Lys+-24 that stabilizes the α-helix (AJ Waring, FJ
Walther, KJ Longmuir, LM Gordon, unpublished data, 2014). MD runs using GRO-
MACS (http://www.gromacs.org) should provide valuable information on the detailed
3D-structures of SP-C mimics in the bilayer (Walther et al., 2010; Schwan et al., 2011). For
simulationsofSP-Cssion-lock1inalipidbilayer-waterbox,the“0ns”modelwasobtained
by first templating its primary sequence (Fig. 1) onto the 2D-NMR structure of porcine
SP-C (Johansson et al., 1994) (PDB: 1SPF). The homology modelled SP-Css ion-lock 1
was centered in a bilayer box with its helical axis normal to the membrane surface, then
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lipid, and finally 79 DPPC lipids and 18 POPC lipids added to fill out the bilayer. In
the GROMACS Version 4.5.5 environment, MD simulations (100 ns) for the SP-Css
ion-lock 1-lipid ensemble in a water box using the ffG53a6 force-field rapidly reached
equilibrium(≤ ∼60–70ns).Theequilibrated“100ns”modelshowsthatthehydrophobic
C-terminus of SP-Css ion-lock 1 inserts as a transmembrane α-helix (residues ∼7–19
and ∼22–32) at a slight tilt (i.e., θ) to the normal of the bilayer surface, and also the
polar N-terminus (residues ∼1–6) interacts as an extended random-coil with polar lipid
headgroups. In particular, the helical axis for the “100 ns” SP-Css ion-lock 1 is tilted at an
angle (i.e., θ ∼ 25◦) from the normal to the membrane surface that is in agreement with
the maximum tilt angle (Θ) from oriented FTIR spectra (i.e., ∼23◦) (see Table 1). The
similarity in the membrane insertion angles for helical SP-Css ion-lock 1 obtained from
MD simulation and polarized FTIR argues that the peptide-lipid bilayers are deposited as
well-ordered multilayers on the germanium crystal with minimal unoriented (isotropic)
peptide.Substantialamountsofisotropicpeptidewouldbeexpectedtoreducethedichroic
ratio R and increase Θ over the actual tilt angle θ, which is not observed in our MD
simulation and polarized FTIR experiments (Fig. 5; Table 1) (Beevers & Kukol, 2006).
The MD simulations and “100 ns” models for SP-Css ion-lock 1, SP-C33 ion-lock 1
and SP-C33 are all similar, with the three SP-C mimics indicating comparable MD tilt
angles(∼20–25◦)fortheirlong(∼22-residues)transmembraneα-helicesthatmatchtheir
polarized FTIR tilt angles (Θ = ∼23◦) (see Table 1). Importantly, close-range salt-bridges
were identified from the “100 ns” models for SP-Css ion-lock 1 and SP-C33 ion-lock 1
in the surfactant lipid bilayer, with gaps of 3.9 and 3.3 ˚ A between the respective Lys+-24
“N” and Glu−-20 “O” pairs (Kumar & Nussinov, 1999; Kumar & Nussinov, 2002) (see
Introduction). Thesalt-bridges for the SP-Cmimics each lieat the centerof the surfactant
lipid bilayer, which is consistent with MPEx calculations indicating that SP-C peptides
bearing ion-locks may readily embed into the lipid bilayer as α-helices (Fig. 4). The
relatively low H/D exchange for the α-helical residues of either SP-C33 UCLA or SP-Css
ion-lock 1 over ∼6 h (Fig. 6) is also probably due to the deep penetration of these SP-C
mimics into lipid bilayers as transmembrane α-helices. Consequently, the high in vitro
and in vivo surfactant activities reported here for SP-Css ion-lock 1, SP-C33 UCLA and
SP-C33 ion-lock 1 (Figs. 7–9) are probably due to each of these SP-C mimics reproducing
keystructuralfeaturesofnativeSP-Cboundtolipidbilayers(seeIntroduction).
Analogous MD simulations were also conducted to determine whether the reduced
surfactantactivitiesofSP-Cffion-lock1reportedherewereduetoalong-rangesalt-bridge
forming between Glu−-20 and Lys+-24 that destabilizes the α-helix (AJ Waring, FJ
Walther, KJ Longmuir & LM Gordon, 2014, unpublished data). Although the Glu−–Lys+
pair converts SP-Cff to principally α-helical SP-Cff ion-lock 1 (Fig. 2A; Tables 1 and 2),
FTIR deconvolutions of SP-Cff ion-lock 1 in lipids indicated lower α-helix (i.e., 44.6%)
than the α-helix for SP-Css ion-lock 1 (63.1%) or SP-C33 UCLA (67.2%). Oriented FTIR
andH/DexchangestudiesonSP-Cffion-lock1furthershowedthatitsshortα-helix(∼15
residues) poorly incorporated in the bilayer (Fig. 6), and also had a maximum tilt angle
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MD simulations confirmed that the “100 ns” SP-Cff ion-lock 1 restricted its shortened
C-terminal α-helix to one leaflet with a tilt (θ ∼ 36◦) that matched the maximum tilt
anglefrompolarizedFTIRexperiments.Thisabnormalmembranetopographyispartially
due to SP-Cff ion-lock 1 forming a disruptive, long-range salt-bridge (8.9 ˚ A) between the
Glu−-20andLys+-24residues(Kumar&Nussinov,2002),whichmayreducehelixstability
(Fig. 6) and lower lipid affinity (Fig. 4). The exposure of the charged side-chain groups
occurring in long-range salt-bridges may promote electrostatic interactions between
either Glu−-20 or Lys+-24 with other membrane components (Kumar & Nussinov, 2002),
including Lys+-24 binding to anionic phosphates in the polar headgroup of POPG. The
trigger for the above “detergent-like” actions with SP-Cff ion-lock 1 is the replacement
of the vicinal serines with phenylalanines. These substitutions significantly increase
the hydrophobicity of the N-terminal domain of SP-Cff ion-lock 1 over that of SP-Css
ion-lock 1, thereby permitting deeper insertion of the N-terminus into the fatty-acyl
regionsofthebilayerand‘snorkeling’oftheC-terminalhelixintotheopposingmonolayer.
Suchdetergent-likepropertiesmayberesponsibleforthelowin vitroandin vivosurfactant
activities obtained for formulations containing SP-Cff ion-lock 1, when compared with
preparationscontainingSP-C33UCLA,SP-Cssion-lock1orSP-Cff(Figs.7–9).
CONCLUSIONS
Results from experiments on our suite of SP-C peptides confirm that a selective
incorporation of salt-bridges produces SP-C mimics that insert into lipid bilayers as
slightly tilted, transmembrane α-helices with high surfactant activity. Our lead peptide
is SP-Css ion-lock 1, an SP-C mimic that shows enhanced in vitro and in vivo surfactant
activities over its parent SP-Css by readily inserting into lipid bilayers as an alpha-helix
that is slightly tilted and spans both monolayers. Importantly, SP-Css ion-lock 1 simulates
well both the structural and functional properties of SP-C33 UCLA, a member of the
SP-C33classofSP-Cmimics.OurworkinghypothesisisthattheSP-Cssion-lock1inlipids
improves its surfactant functions by stabilizing α-helix through a close-range salt-bridge
between the Glu−-20 and Lys+-24 residues. As a further test of this proposition, more
detailed 3D information on the structure and membrane topography of SP-C ion-locks
will be obtained using 13C-FTIR spectroscopy (Gordon et al., 2000; Waring et al., 2005),
2D-NMR spectrometry (Sarker et al., 2007) and/or all-atom MD simulation techniques
(Walther et al., 2010; Almlen et al., 2010). Additionally, polarized FTIR spectra of SP-C
mimics in surfactant lipids should indicate the fatty-acyl chain orientation with respect to
the peptide helical axis, and likewise show if there are any protein-induced perturbations
in lipid conformations (Clercx et al., 1995). SP-C ion-lock peptides will also be modified
to determine whether their surfactant properties may be further optimized. Because the
palmitoyls of native SP-C have been proposed to increase surfactant activity by physically
coupling stacked lipids to the monolayer (Leonenko et al., 2007), future atomic force
microscopy (AFM) (Ding et al., 2001; Frey et al., 2010) and functional studies may assess
if dipalmitoylated SP-Css ion-lock 1 similarly shows enhanced properties through an
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salt-bridges affect either the self-association of SP-C ion-locks or the binding of SP-C
ion-lockstoSP-Bmimicsorlipidensembles(Waltheretal.,2010).
Lastly, in vivo experiments will determine whether synthetic preparations containing
SP-B analogs and SP-C ion-locks may be superior to single-peptide surfactants in
the treatment of NRDS and ALI/ARDS. In earlier collaborative studies (Almlen et al.,
2010), we investigated the in vivo activities of Mini-B (i.e., MB, a 34-residue ‘short-cut’
version of SP-B with an engineered turn linking the N- and C-terminal helical domains)
and/or SP-C33 with synthetic lipids in preterm newborn rabbits. Treatment with either
Mini-B or SP-C33 increased tidal and lung gas volumes, while combination therapy
demonstrated an additive effect in this validated animal model for NRDS (Almlen et al.,
2010). More recently, animal models of lung-lavaged ARDS and chemically induced ALI
weretreatedwithSuperMini-B(i.e.,SMB,a41-residuetruncatedversionofSP-B,withthe
seven-residueN-terminusofSP-BaddedtotheN-terminusofMini-B)andSP-C33UCLA.
Synthetic formulations using either SMB or SP-C33 UCLA improved blood oxygenation
anddynamiccomplianceintheseARDS/ALImodels,whilecombinationtherapyindicated
an additive effect (Walther et al., 2014). Similar in vivo experiments in which the SP-C33
class is replaced with SP-Css ion-lock 1 may show if SP-C mimics with salt-bridges may
alsobetherapeuticallybeneficial.
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